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Proteins are essential macromolecules for the proper function and proliferation of
life in tandem with carbohydrates, lipids, and nucleic acids. Even with our current
understanding, novel proteins and protein-protein interactions are continuously being
discovered, providing a better and clearer picture of cellular processes. In this
dissertation, the work presented will focus on tackling how proteins interact with their
ligands and what this tells us about the protein’s structure and function by utilizing
biophysical techniques encompassing nuclear magnetic resonance spectroscopy and
isothermal titration calorimetry. In chapter 2, we have studied the protein-protein
interactions of cluster of differentiation 47 (CD47) and protein linking integrin associated
protein to the cytoskeleton 2 (PLIC-2) and confirmed that the two do not associate in vitro
under the conditions tested. It was anticipated that PLIC-2 could be a means for CD47 to
modulate the cytoskeletal framework, but the lack of direct binding weakens that
possibility. In chapter 3, the interaction between butyrophilin 3A1 (BTN3A1) and
phosphoantigens (pAg) were explored, focusing specifically on the region between
BTN3A1’s transmembrane helix and B30.2 domain, denoted juxtamembrane (JM) region.
We have found that the JM region was able to weakly associate with pAg, where the
important functionality is the negatively charged diphosphate moiety. This association is
potentially vital for the activation of BTN3A1, where ligand association was found to be
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able to induce a conformational change within the intracellular region of BTN3A1. In
chapter 4, we explored the use of small molecules in order to probe the protein surface
through NMR. By using select hydrophobic probes, it is possible to quantitate the overall
surface hydrophobicity of a protein, which is important for understanding protein stability
as solution properties, such as aggregation, have been linked to hydrophobic interactions.
I have added an appendix chapter A1, which is related to my minor contribution to the
structural refinement of skelemin and understanding its interaction with integrin. All in all,
the work presented here focuses on protein interactions and how it can be related to its
biological role and solution properties.
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Chapter 1 – Introduction

Chapter 1 – Introduction
Proteins as a whole have diverse roles and functions within the cell, such as a cell
division, enzymatic, protein expression regulation, or even apoptosis. Understanding
individual biological processes is fundamental for comprehending medical problems that
may arise from protein mutations and/or deletions, but is an arduous task as the
mechanical workings within the cell is a complex interplay of proteins, nucleic acids, lipids,
carbohydrates, and small molecules. In this dissertation, I will investigate various proteins,
such as CD47 or BTN3A1, and their binding partners in vitro to better understand their
structure and function. There are numerous ways and instrumentation for a scientist to
conduct research, but this introduction will provide a brief overview of the main techniques
used in this dissertation. There are multiple references if a more in-depth explanation is
required [1-5].

1.1 – Isothermal Titration Calorimetry
Isothermal titration calorimetry (ITC) is a technique that can be utilized to
characterize the thermodynamic parameters of interactions by directly measuring the
heats of binding at constant temperature. These processes may be endothermic or
exothermic, depending on whether or not they use or release heat, respectively. The heat
detected is of particular importance as ITC is able to directly determine the change in
enthalpy (ΔH) as shown in Figure 1.1. From the titration data, the equilibrium association
constant (Ka) is determined from the slope at the inflection point.
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Figure 1.1. Diagram of Important Parameters Determined by ITC. The binding curve
presented here is a simulated curve using an independent binding model in which the
concentrations were 800 µM and 100 µM for the titrant and protein, respectively. The K d
was set to 1 µM. The ΔH is determined by measuring the maximal difference in heat
(between the dotted lines) and the slope (grey line) at the inflection point is related to the
binding affinity, Ka.

The determination of both the ΔH and Ka is very useful because they can be used to
calculate the rest of the thermodynamic parameters through the equations:
∆𝐺 = −𝑅𝑇𝑙𝑛𝐾𝑎

(1)

∆𝐺 = ∆𝐻 − 𝑇∆𝑆

(2)

where ΔG is the change in Gibbs free energy, R is the gas constant, T is the temperature,
and ΔS is the change in entropy. Equation 1 reflects the system at equilibrium, which
allows for the calculation of ΔG at the experimental temperature. Afterwards, the ΔG can
be plugged in equation 2 in order to determine the ΔS. As a result, we can be able to
predict the thermodynamic parameters of the system of interest, where we can observe
if it is enthalpically and/or entropically favorable. This is useful is gauging the strengths of
2
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interactions, where entropic gains are generally from hydrophobic interactions whereas
favorable enthalpies can be from hydrogen bonds and charge-charge interactions.
Though ITC is a powerful tool for evaluating the thermodynamic parameters, there
are several practical considerations for performing ITC runs. The ITC measures the total
heat from the system, which means that it detects the formation and/or breaking of
hydrogen bonds from ligand-ligand and ligand-solvent interactions on top of the ligandprotein interaction of interest. As such, this necessitates the evaluation of a titration
control, where the ligand is titrated into the buffer in the absence of protein. This measures
the heats of dilution, in which the ligand goes from a concentrated to a dilute state. The
heat differences due to the ligand-ligand and ligand-solvent are subtracted from the actual
experiment to more properly characterize the ligand-protein association. Another
consideration to factor in is the c value, which is a relationship between the K a and the
concentration of the protein in the cell:
𝑐 = 𝐾𝑎 𝑛[𝑃]

(3)

where the n is the stoichiometry and [P] is the protein concentration in the cell. The
acceptable range of the c value is generally between 10-100, which provides a
reasonable binding curve as shown in Figure 1.1 (c value = 100). For the low volume
NanoITC, this is appropriate for protein based interactions whose Kd values are usually
in the low µM range as it translates to needing a protein concentration of approximately
100 µM. Though the ITC is able to detect bindings within the nM to mM range, obtaining
workable protein concentrations would be difficult as mM affinities require very high
concentrations that may not be possible due to protein stability and aggregation. On the
other hand, nM affinities require lower concentrations, which consequently means lower
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sensitivity due to the reduced heats from binding. However, there are workarounds, such
as competitive displacement experiments.

1.2 – Nuclear Magnetic Resonance Spectroscopy
1.2.1 – Overview of Key Principles
Nuclear magnetic resonance (NMR) spectroscopy is a sensitive and robust
technique that relies on a property called the nuclear spin, I, that is dependent upon the
composition of the nucleus (number of protons and neutrons). When subjected to an
external magnetic field, there will be a (2I + 1)-fold degeneracy. If the nuclear spin is 0 as
in the case for

12C,

then there is only one energy level and excitation is not possible,

rendering the nucleus to be undetectable by NMR. Since quadrupolar nuclei (I > 1/2)
produce a much more complex spectrum due to multiple energy states, this overview will
encompass the nuclei (1H, 13C, 15N) that possess a nuclear spin of 1/2. The relative energy
difference between the two energy levels is directly proportional to the gyromagnetic ratio
(an intrinsic property of the nucleus), γ, and the strength of the external magnetic field,
Bo. As such, higher sensitivities can be achieved by observing nuclei with a larger
gyromagnetic ratio like 1H as well as utilizing stronger external magnetic fields. Since
there is an energy difference between two states, it is possible to excite the nuclei as:
∆𝐸 = ℎ𝑣

(4)

where h is planck’s constant and ν is the frequency.
Excitation is performed through the application of radio-frequency pulses for a
specific duration, which leads to the rotation of the bulk magnetization from the z-axis. A
complete transfer of the bulk magnetization to the xy-plane would correlate with a 90o
4
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change, which is denoted as a 90o pulse. The bulk magnetization would then process
about the xy-plane due to its angular momentum. The analogy commonly given is the
spinning top, who spins stably if the vertical axis is aligned but has a precessional motion
if the vertical axis is tilted.
The importance of the magnetization in the xy-plane is because a rotating
magnetic field generates an electric current that is detectable by the instrument. The
output is a digitized plot of the oscillation about the x or y plane called the free induction
decay (FID). The signal decays over time due to natural relaxation processes that reduce
the magnetization in the xy-plane to 0 and brings the bulk magnetization back to the zaxis. The conversion from time to frequency domain is commonly done through the
Fourier Transform in order to present the data as commonly seen for 1D, 2D, and 3D
spectra.

1.2.2 – Chemical shifts, Chemical Exchange, and Binding
Now, there is a slew of information that can be obtained from NMR. One piece of
information comes from the chemical shift values. As stated before, the frequency for
excitation depends on the external magnetic field. However, there is a local magnetic field
as the nuclei also behave as bar magnets, which ultimately leads to minor, but detectable,
differences in the larmor frequencies. The information of the local environments is useful
for determination if the protein is folded and what kind of structure it has because the
chemical shifts of amino acids in α-helix, β-sheet, or random coil have been extensively
tabulated throughout the years. Furthermore, following chemical shifts and chemical shift
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Figure 1.2. Diagram of Chemical
Exchange and Motional Regimes.
This depicts what we can expect to see
in an NMR spectrum at the different
motional

regimes

depending

on

exchange rate (kex) and chemical shift
difference (Δδ), where fast is where the
kex >> 2πΔδ, intermediate is kex ~ 2πΔδ,
and slow is kex << 2πΔδ. The fast
exchange regime shows an averaged
peak that may show chemical shift
changes when moving from 100% population A (black line) to 100% population B (grey
line). The intermediate exchange also shows chemical shift changes, but is also
accompanied by line broadening. Slow exchange does not show any sort of chemical
shift changes, but rather shows the two distinct peaks and their relative populations.

differences are standard practices for studying protein-protein and protein-ligand
interactions. This is based on the equilibrium:
𝐴→
←𝐵

(5)

where the protein is able to interconvert between states A and B. This can apply for
multiple conformations, but the common scenario would be for binding to ligands/proteins,
where A is the apo state and B is the bound state. As the chemical shift is dependent
upon the localized magnetic field, any association will mean that B has different chemical
shifts from A located at the direct binding site or potentially indirect conformational
changes. Now, what we actually observe is based on the rate of exchange, the chemical
shift difference, and populations of A and B as shown in Figure 1.2. Nonetheless,
chemical shift perturbations are a useful tool for detecting binding.
6

Chapter 1 – Introduction

1.2.3 – Paramagnetic Relaxation Enhancement
Paramagnetic Relaxation Enhancement (PRE) experiments rely on the use of
paramagnetic compounds, who possess an unpaired electron. The unpaired electron, like
the nucleus, is able to generate local magnetic fields. However, the unpaired electron has
a much larger magnetic moment than the nucleus, so that its presence greatly enhances
the relaxation rate of nearby atoms up to ~10-25Å away. Thus, one can compare the
differences in spectra of a protein in the presence and absence of a paramagnetic
compound, where affected residues would have a reduced signal to noise ratio due to the
rapid relaxation rate. This process can be utilized so that it is possible to detect solvent
exposed residues, which could be subsequently protected upon complex formation.
Alternatively, covalently attaching a paramagnetic compound to the protein can provide
distance restraints by deciphering which residues are nearby in space.

1.2.4 – Transverse Relaxation Time
Transverse Relaxation Time (T2) is the time it takes for the magnetization in the
xy-plane to return to equilibrium. The main process that causes T2 relaxation is chemical
shift anisotropy (CSA), which is the minor fluctuations in the individual localized magnetic
environments. As mentioned previously, the bulk magnetization is excited and then
detected through its precession within the xy-plane. However, this bulk magnetization is
comprised on individual spins that are not all identical due to anisotropy, which causes
the same atom (on different proteins) to precess at a different rate. This results in
decoherence over time due to minor variability within the local field, where the bulk

7
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Figure 1.3. Diagram of Decoherence. This schematic shows the bulk magnetization
after excitation residing on the +y axis. After a certain period of time, the spins begin to
precess in the xy-plane at various frequencies, leading to phase decoherence. As a result,
the bulk magnetization, which is the sum of all the individual magnetization vectors,
effectively gets reduced over time.

magnetization is reduced, causing the reduction of detectable signal (Figure 1.3). This
effect is related to the rotational correlation time, τc, which is the average time for the
molecule to rotate one radian. It is important to note that τc is dependent upon the volume
the molecule occupies, which implies that larger molecules like proteins will generally
have slower correlation times and, thus, a shorter T2 in comparison to small molecules.
Another key factor that contributes to T2 relaxation is magnetic field
inhomogeneities. Similarly to CSA, the precession of an atom in the xy-plane can be
altered due to abnormalities in the Bo, such that the Bo felt by one atom is not the same
at a different location in the NMR test tube. This is not a natural process by which
relaxation occurs, but is rather due to experimental limitations in generating a uniform
magnetic field through electrical currents flowing through a large superconducting coil and

8
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Figure 1.4. Representation of Spin
Echo and Usage. (A) shows the
simplest spin echo pulse sequence
(CPMG), where the proton is initially
excited by a 90o x-pulse. After time,
τ, a 180o y-pulse is applied to invert
the magnetization in the x-axis. The
spins are allowed to precess for
another time, τ, for refocusing before
acquisition. The spin echo, τ-180o-τ,
can be repeated n times as needed.
(B) is a visual representation of the
refocusing as shown by the three
colored arrows, who precess at
different rates.

smaller coils called shims. Fortunately, these experimental artifacts can be corrected for
by applying a refocusing pulse.
A spin echo pulse sequence, where the simplest one is the Carr-Purcell-MeiboomGill (CPMG) pulse sequence (Figure 1.4), applies an 180 o y pulse after a period of time,
τ, that inverts the magnetization on the x-axis. After the spins precess for an identical
period of time, τ, the magnetization will all converge to a single point (Figure 1.4). As a
result, the influence of experimental artifacts are negated through the refocusing pulse
and the T2 relaxation seen is the true T2 value. It is important to note that the effects of
CSA are not mitigated with this pulse sequence as this is a natural process that is
fundamentally tied to random molecular motions whereas field inhomogeneities are not
random and dependent upon the location within the magnet.
9
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Chapter 2 – Uncovering if PLIC-2 is a
Cytoskeletal Adaptor Protein of CD47
Adapted from: Nguyen, K., Puthenveetil, R., and Vinogradova, O. Investigation of the
adaptor protein PLIC-2 in multiple pathways, Biochem. Biophys. Rep., 2017, 9: 341-348.

2.1 – Introduction
2.1.1 – Overview of CD47
Cluster of differentiation 47 (CD47) is a ubiquitously expressed cell surface
receptor [1] that consists of an extracellular IgV-like domain, five transmembrane helices,
and a short unstructured cytoplasmic tail [2]. There are four different isoforms of CD47,
differing only in their length of the cytoplasmic tail, where isoform 1 is the shortest and
isoform 4 is the longest (Figure 2.1B). Each isoform is differentially expressed as isoform
1 is found in keratinocytes, isoform 2 is ubiquitously expressed, isoform 3 is
predominantly in the liver, and isoform 4 is found within the brain and peripheral nervous
system [3, 4]. Though isoform 2 is the most abundantly expressed, it is unclear if there is
functional relevance between the isoforms [3].
Nonetheless, CD47 was uncovered to be a significant player in the recognition of
self, a mechanism by which our immune system precludes the removal of our own cells.
CD47’s IgV-like domain is able to associate with signal regulatory protein-α’s IgV-like
domain (SIRP-α), leading to the downstream activation of protein tyrosine phosphatases
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Figure 2.1. Overview of PLIC-2 and CD47 Structure as well as the Potential Pathways. (A)
Schematic showing the different domains and motifs of PLIC-2. It contains a well characterized Nterminal UBL (ubiquitin like) domain and a C-terminal UBA (ubiquitin associated) domain. Interspersed
between the two is the Body region which contains four Sti1 like domains and a repeat of twelve PXX
motifs. (B) Schematic showing the overall structure of CD47. It consists of an N-terminal extracellular
IgV domain, five trans-membrane helices and a C-terminal cytoplasmic tail. The tail is further
differentially spliced from a single splice donor yielding the four isoforms of CD47. (C) A model
representation showing the two pathways involving PLIC-2: (i) the proteasomal degradation pathway.
This pathway is unrelated to the presence of CD47. Here the UBA domain of PLIC-2 binds to
polyubiquitin chain bound to the substrate while the UBL domain interacts with the proteasome
delivering the payload for degradation; (ii) the cytoskeletal regulation pathway. Central to this pathway
is PLIC-2 which acts like an adaptor protein linking CD47 to Vimentin, an intermediate filament, hence
by forging a link between the outer cell membrane and inner cell cytoskeleton. PLIC-2 has been
proposed to interact with the cytoplasmic tail of CD47 [18]. We envision this interaction to occur in one
of two ways: (ii-a) The UBA (or UBL) domain of PLIC-2 interacts with CD47, while the Body region
interacts with vimentin filaments; (ii-b) the Body region of PLIC-2 interacts both with CD47 and
Vimentin filaments. Meanwhile the UBL and UBA domains interact with each other.
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(SHP-1 and SHP-2) and inhibition of phagocytosis, especially in the case of mature red
blood cells [5-7]. Furthermore, CD47 was found to be involved in regulation of
angiogenesis and blood flow through its association with thrombospondin 1 (THBS1) and
vascular endothelial growth factor receptors (VEGFR) [8]. Intriguingly, CD47 is also
known by the name of integrin associated protein (IAP) due to experimental evidence
where it co-precipitated with integrin αvβ3 [9] and was further expanded to include integrin
αIIbβ3, α2β1, and α4β1 [10]. After being found to be identical to CD47, it is no longer referred
to as IAP due to the fact that it is expressed and has a functional role in erythrocytes, who
lack integrins [1].
However, the molecular details of how CD47 is able to modulate cellular functions
is currently unclear and has led to the interest in discovering novel proteins that may
directly interact with CD47. There has not been much success, but there was a report by
Wu and colleagues [11] that they had discovered two proteins that co-precipitated with
the cytoplasmic tail (isoforms 2 and 4) of CD47. The proteins were found to increase
CD47 related cell spreading and influenced the localization of vimentin filaments. This
was a promising basis for how CD47 could modulate the cellular cytoskeleton, which is
how the authors derived the name PLIC-1 and PLIC-2 (Proteins linking IAP with
cytoskeleton).

2.1.2 – Who are the PLIC Proteins?
Though they were discovered and named PLIC due to aforementioned evidence,
PLICs are identical to a family of proteins called ubiquilins, which are human orthologs of
the yeast Dsk2 family of proteins [12]. PLIC consists of a family of four homologous
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proteins, PLIC-1 through 4. All contain a ubiquitin-like (UBL) amino-terminal domain; a
body region, which is predominantly predicted to be disordered by DISOPRED [13] and
Jpred [14] containing STI1 (stress inducible) heat-shock protein binding motifs [15, 16];
and a carboxyl-terminal ubiquitin-associated (UBA) domain (Figure 2.1A) [17]. PLIC-1
and 2 are localized to the cytoplasm [18], PLIC-3 [19] is found in the testis and PLIC-4 is
localized to the cell nucleus [20]. As mentioned previously, PLIC-1 and PLIC-2, also
known as ubiquilin 1 and 2 respectively, had been shown to modulate the cytoskeleton
through CD47. The direct interaction between CD47 and PLIC can be envisioned in
Figure 2.1C, where it could be the individual UBL/UBA or the body region in direct
association with CD47. The linkage to vimentin is most likely mediated through the body
region.
However, there have been conflicting data arising, where another study showed
that double labeled immune-fluorescence of PLIC-1 and vimentin filaments did not show
any co-localization [21] and that PLIC-1, but not PLIC-2, binds to Gβγ subunit of G
proteins and interferes with its functionality. This was based on the observation that PLIC2 was predominantly present in the cytoplasm and never co-localized to the plasma
membrane [22]. In addition, PLIC-1, but not PLIC-2, has been shown to inhibit Jurkat Tcells migration by interacting with the βγ-subunit of the heterotrimeric G-protein [22]; and
stabilize intracellular GABAA receptors to promote their accumulation within the plasma
membrane [23]. Interestingly, PLIC-2, but not PLIC-1, down regulates endocytosis of the
two unrelated GPCRs, V2 vasopressin receptor and beta-2 adrenergic receptor [24].
Though these studies highlight PLICs involvement in diverse cellular functions as a key
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regulatory molecule, they seem to contradict its primary discovered role as a structural
adaptor protein linking IAP/CD47 to cell cytoskeleton.
Furthermore, PLICs have been implicated to be involved in the ubiquitin mediated
proteasomal degradation pathway. The primary machinery for this is the 26S proteasomal
complex that is composed of a 19S regulator complex and 20S core complex, where
polyubiquitinated proteins ultimately are degraded [25]. Evidence has been shown that
the S5a subunit of the 19S component binds to the UBL domain of PLIC-2 [26]. Given
that PLICs contain both a UBL and UBA domain and that other UBL-UBA shuttle proteins
like Rad23 and Dsk2 have been characterized [27], it may be that PLIC serves as a shuttle
for proteosomal degradation (Figure 2.1C) rather than a cytoskeletal adaptor protein.
It is a bit puzzling as to how two diverse modalities are built into a single structural
design of these proteins. It seems pertinent to ascertain whether the UBL/UBA system is
directly involved in linking cell surface receptors to intermediate filaments or whether it
acts as a shuttle protein delivering its payload to the proteasomal complex for
degradation. With the aim to reconcile these differences and understand which of the two
pathways PLIC actually follows, we set to investigate the individual components involved
in the interactions. We focused on uncovering if there was UBL/UBA self association or
UBA/Ubiquitin binding, which are commonly seen for UBL-UBA shuttle factors, and if
there was direct association with the cytoplasmic tail of CD47 isoform 4.

2.2 – Materials and Methods
Cloning of PLIC-2 and CD47 Constructs
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PLIC-2/UBLN-2 (Accession number: Q9UHD9) UBL domain UBLN21-107 present
in pET23a vector, was kindly provided by Dr. Walters (NCI. USA). PLIC-2 UBA domain
UBLN2578-624 was sub-cloned into pET15b vector using BamHI and HindIII restriction
sites. PLIC-2 Body region UBLN2108-580 was sub cloned into pET15b using NdeI and
BamHI restriction sites. To ensure accurate measurement of the recombinant protein
concentration, a single Tryptophan residue was inserted into the corresponding vectors,
for both UBL and UBA, following the six Histidine tags.
We used the longest isoform of CD47 (Isoform-4) as classified in the initial paper
[18]. As per the Uniprot classification, this is annotated as Isoform-1. For this work, we
will be following the classification from the original paper. Two constructs of CD47
isoform-4 (Accession no.: Q08722-1) were designed for this study, (i) CD47

290-323

containing the residues comprising its cytoplasmic tail (CD47-CT) and (ii) CD47

269-323

containing the residues comprising its last transmembrane helix along with its cytoplasmic
tail (CD47-TMCT). The resulting amplicons were cloned into pET15b (for CT) (Novagen,
USA) and pDB.His.MBP vector (for TMCT) (DNASU plasmid depository, USA) using the
cutting sites NdeI and BamHI for the former and BamHI and HindIII for the latter. The
pDB.His.MBP vector contains a Histidine-affinity tag and a MBP-fusion protein, separated
from CD47’s sequence by a TEV protease cleavage site. Three additional glutamates
were added before the N-terminal sequence to ensure proper accessibility of the cleavage
site for proteolysis.

Expression and Purification of the Recombinant Proteins
Expression
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All constructs were expressed in E. coli BL21 (DE3) (NEB, USA). Cell cultures
were grown in either LB or M9 minimal media supplemented with 15N-labeled ammonium
chloride as the sole nitrogen source at 37oC. When the cells reached an optical density
(OD600) of ~0.4 to 0.6, the cultures were transferred to a shaker at room temperature (for
most proteins) or a 17oC shaker (for PLIC-2 Body region), and left overnight after
induction with 0.5-1mM IPTG.

Purification
UBA, UBL, Body, and CD47 constructs were purified using similar protocols with
procedure variations outlined below. Harvested cells were resuspended and lysed using
a French Press (Thermo Electron, USA). The supernatant was bound to Ni-NTA resin
(Qiagen, USA) at 4oC for an hour, rinsed with ten column volumes of the wash buffer
before elution. The eluate was further subjected to size exclusion chromatography (SEC)
on a Superdex 75 (GE Healthcare, USA) for UBL and UBA domains, or Superdex 200
(GE Healthcare, USA) for CD47-TMCT. In addition to Ni-NTA purification the Body region
was further purified using anion exchange chromatography

on Resource Q (GE

Healthcare, USA), with a 0-30% gradient of Buffer A (20mM Tris, pH 8.0) and Buffer B
(20mM Tris, 1M NaCl, pH 8.0). The Body containing fractions were further subjected to
SEC on a Superdex 75 column.
CD47-CT expressed in inclusion bodies was purified under denaturing condition.
Briefly, cells were resuspended in 6M GuHCl in Tris buffer saline (TBS) buffer pH 8.0.
Following lysis the supernatant was separated through centrifugation at 10,000 rpm and
mixed with Ni-NTA resin at room temperature for 2 hours. The resin was rinsed first with
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four column volumes of 8M urea in TBS with 10mM imidazole. Elution was carried out in
the 8M Urea buffer containing 400mM imidazole. The eluate was loaded onto a Proto 300
C4 column (Higgins Analytical Inc., USA) and purified using a 10-40% gradient of (Buffer
A: 90% H2O, 10% Acetonitrile, 0.1% TFA and Buffer B is 10% H2O, 90% Acetonitrile,
0.1% TFA). CD47-CT containing fractions were pooled and lyophilized (MillRock Tech.,
USA).

Nuclear Magnetic Resonance Spectroscopy
15N-labeled
15NH Cl
4

proteins were overexpressed in M9 medium supplemented with

as the sole nitrogen source.

15N-NMR

experiments were performed with a

concentration of 75-150 µM on a Varian 600 MHz spectrometer equipped with an inverse
triple-resonance cold probe at 25oC. All spectra were processed with NMR Pipe [28] and
analyzed in CcpNmr software suite [29] made available through NMRBox.
For CD47-TMCT nanodiscs experiments,

15N-CD47-TMCT

unlabeled UBL at a ratio of 1:5 and Body region at 1:3.
unlabeled CD47-TMCT at a ratio of 1:5, whereas

15N-UBA

CD47-TMCT at a ratio of 2:5. For CD47-CT experiments,

was titrated with

15N-UBL

was titrated with

was titrated with unlabeled
15N-UBL

was titrated with

unlabeled CD47-CT at a ratio of 1:10 and 15N-UBA was titrated with unlabeled CD47-CT
at a ratio of 1:10. For PLIC-2 self-association experiments,

15N-UBA

was titrated with

unlabeled UBL at ratios of 1:1, 1:3, 1:5, and 1:10. For UBA and ubiquitin experiments,
15N-UBA

was titrated with unlabeled ubiquitin at ratios of 3:1, 2:1, 1:1, 1:2, 1:3, 1:5, 1:10.

Kd values were determined form the chemical shift perturbations calculated using the
following equation [30]:

18

Chapter 2 – Uncovering if PLIC-2 is a Cytoskeletal Adaptor Protein of CD47

∆𝛿 = √0.5(𝛿𝐻2 + (𝛼𝛿𝑁2 ))

(1)

where the scaling factor, α, was set to 0.15. The plot of the chemical shift perturbation vs.
molar ratio was fitted to the equation below to define the K d [31]:
𝐾

2

𝐾

∆𝛿𝑜𝑏𝑠 = 0.5∆𝛿𝑚𝑎𝑥 (1 + 𝑥 + [𝑃]𝑑 − √(1 + 𝑥 + [𝑃]𝑑 ) − 4𝑥 )
0

where [P]0 is the concentration of

0

15N-UBA

(2)

PLIC-2 and x is the molar ratio of UBL or

ubiquitin to UBA.

Isothermal Titration Calorimetry
All ITC experiments were performed using a low volume Nano-ITC (TA
instruments, USA). The titrations were done at 25oC with 200 RPM mixing, 300 s injection
intervals, and 2.5 µL injections. The buffer used was 40 mM NaPO4, 20mM NaCl, 0.5 mM
EDTA, pH 7.0. The protein concentrations for the syringe and sample cell were as follows:
0.95 mM UBL PLIC-2 and 0.14 mM CD47-CT, 0.39 mM UBA PLIC-2 and 0.05 mM CD47CT, 0.49 mM CD47-CT and 0.05 mM Body PLIC-2, and 0.49 mM CD47-CT and 0.04 mM
Body PLIC-2. For nanodiscs, 0.35 mM UBL PLIC-2 and 0.07 mM CD47-TMCT; 0.32 mM
UBA PLIC-2 and 0.07 mM CD47-TMCT. Data analysis was done with the NanoAnalyze
Software (TA Instruments, USA) suite using “independent” model algorithm.

Molecular Modeling
PLIC-2 UBA was modeled through Phyre 2 [32] web server using PLIC-1 UBA
domain as a template which shares 98% identity. Models of the protein complexes (PLIC2 UBA-UBL and PLIC-2 UBA-Ubiquitin) were calculated through the HADDOCK (High
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Ambiguity Driven protein-protein DOCKing) [33] webserver using the chemical shift
perturbation data obtained from NMR HSQC titration experiments. The structures of the
participating proteins were acquired from the RCSB database (PLIC-2 UBL: 1J8C,
Ubiquitin: 2JY6, PLIC-2 UBA: 2JY5).

2.3 – Results and Discussion
2.3.1 – Determination of the UBA/UBL Self Association
We first tried to ascertain the involvement of PLIC-2 in the proteasomal
degradation pathway. We initiated this by determining whether the two terminal UBA and
UBL domains of PLIC-2 interact with each other (Figure 2.1C (i)).

15N-HSQC

based

chemical shifts perturbation (CSP) experiments were employed, where 15N labeled PLIC2 UBA was titrated against unlabeled PLIC-2 UBL. Peaks representing maximum
observed perturbations (marked with asterisk on Figure 2.2), were used to calculate the
Kd values using the equations summarized in the methods section. The average K d value
obtained was 175±25 µM, which is comparable to the previously reported K d value of
80±15 µM measured for Dsk2, a yeast homolog of PLIC proteins, [34]. It is known that for
UBL-UBA proteins involved in proteasomal degradation, UBL interacts with the
proteasome while UBA binds to polyubiquitinated substrates [17].
From reliable partial assignments transferred from PLIC-1’s UBA domain [35], we
identified most of the PLIC-2 UBA residues which undergo perturbations in the presence
of PLIC-2 UBL. These residues either belong to the loop region connecting helices α1
and α2 (M592-F594) or are located within helix α3 (I615-E616 and L619) of which I615 showed
minimal shifts. These positions match well with the corresponding Dsk2 residues M 342-
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Figure 2.2. PLIC-2’s UBA Domain is Able to Self-Associate with its UBL domain.
15N-HSQC

titration experiments of PLIC-2

15N-UBA

domain in the presence of PLIC-2

UBL domain at a UBA to UBL molar ratio of 1:1, 1:3, 1:5, and 1:10. Partial amino acid
assignments were achieved by aligning the 15N-HSQC to that of PLIC-1 UBA domain [35].
The inset shows a molecular model displaying the interaction of UBA (grey) and UBL
(red) as determined by HADDOCK. Two residues M and G showing maximum
perturbation are shown as slices on the right.

F344 from the same loop region and L365-D366, L369 from the α3 helix. Defining the binding
site are residues M342/592, which fits snugly in the hydrophobic cavity of UBL, and L365/I615
and L369/619, which reinforce the hydrophobic core. It is likely that the flexibility required for
the two terminals domains to interact with each other is satisfied by having a Body region
that is largely disordered.
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Figure 2.3. PLIC-2’s UBA Domain Exhibits Large Chemical Shift Perturbations upon
Titration with Ubiquitin.

15N-HSQC

titration experiments of PLIC-2

15N-UBA

domain in

the presence of ubiquitin (Ub) at a UBA to Ub molar ratios of 3:1, 2:1, 1:1, 1:2, and 1:3.
Ratios 1:5 and 1:10 are not shown as the spectra reached a saturation at 1:3. A molecular
model, determined by HADDOCK, of UBA PLIC-2 (grey) and ubiquitin (red) as inset in
the spectra. On the right, specific peaks are shown separately to better capture the
chemical shift perturbations. Two residues M and G displaying intermediate exchange
are shown as slices on the right.

2.3.2 – Uncovering if UBA and Ubiquitin Interacts
Thus, we next examined the ability of PLIC-2 to bind ubiquitinated substrates
through the interaction of PLIC-2 UBA domain with Ubiquitin (Ub). Our titration
experiments demonstrate a stronger binding affinity of UBA for Ub, as exemplified by the
pronounced CSPs in 15N-HSQC spectra (Figure 2.3). The Kd value for this interaction was
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determined to be 8.1±1.5 µM by averaging fits from peaks with pronounced perturbations,
which is similar to PLIC-1’s affinity for ubiquitin (Kd ~20 µM) [35]. CSP data was further
utilized to generate a model of the binding interface between UBA-UBL and UBA-Ub
using HADDOCK, which is presented as inset within the spectra in Figures 2.2 and 2.3.
Intermolecular interaction between UBA and Ub is stronger than with UBL and their
binding interfaces involves the same core residues in addition to other exclusive to the
UBA-Ub interactions reflective of stronger binding. CSP data obtained from our titration
experiments of 15N UBA with Ub highlights residues M592-F594 from the (helix α1/ α2) loop
region and A614-L619 belonging to helix α3 that are involved in this interaction. Majority of
the perturbations belong to the fast exchange regime as only chemical shift perturbations
were observed. However, residues M592-G593 displayed both chemical shift perturbations
and peak broadening indicative of intermediate exchange. This is part of the canonical,
M-G-F containing binding site conserved throughout UBA domains of PLIC/Dsk2 and
hHR23/Rad23 proteins. In addition, I615-E616 and L619 from α3 showed significant
perturbations, as has been observed for I580-E581 and L584 form PLIC-1 where they form
close contacts with the hydrophobic patches of Ub [36]. Interestingly, T607, the last residue
from the helix α2 showed shifts which can be attributed to its close proximity to A614 on α3
which exhibited strong CSP a feature also observed with PLIC-1. All together, we can
conclude that the UBA-UBL and UBA-Ub interactions in PLIC-2 share the same binding
interface, which is exemplified in the HADDOCK models presented as insets in Figure 2.2
and 2.3.
Now, in order for PLIC proteins to participate in the proteasomal degradation
pathway, two events need to occur. First, the UBL domain needs to interact with the
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proteasome and, second, the UBA domain needs to interact with ubiquitin. The former
has already been established for PLIC-2, where the UBL domain has been shown to
complex with hRpn13 (Adrm1) [37], which is a subunit of the 19S regulatory particle of
the 26S proteasome. In this chapter, we determined that PLIC-2 UBA domain is able to
associate with ubiquitin. From our Kd estimation, the PLIC-2 UBA-Ub binds stronger than
UBA-UBL. Given that UBA and UBL domains associate with each other, a stronger affinity
of the PLIC-2 UBA domain for ubiquitin implicates the disengagement of the UBA-UBL
domains in the event of PLIC binding to the polyubiquitinated substrate en route to the
proteasome. This strongly suggests the role of PLIC-2 as a shuttle protein transferring its
cargo to the proteasome for degradation.

2.3.3 – Evaluating Binding of CD47 to the UBL and UBA Domains
Next, we moved on to investigate the second half of our model, testing PLIC-2 as
an adaptor protein linking the cell membrane to the cytoskeleton through the cytoplasmic
tail of CD47 (Figure 2.1Cii). This was achieved by determining interactions occurring
between CD47 and (a) the two terminal UBA/UBL domains of PLIC-2 or (b) the Body
region of PLIC-2. Two constructs of CD47 were utilized, one containing the cytoplasmic
tail region (CT) and the other comprising of the last transmembrane helix in addition to
the cytoplasmic tail (TMCT). This helped investigate interaction at both the aqueous and
membrane/water interface. Since CD47 is a mammalian receptor protein, we assessed
the possibility of posttranslational modifications (PTM) using several PTM databases from
Uniprot. We found that although there are ten positions that potentially undergo PTM, the
last is located at residue 206. As our longest CD47 construct (TMCT) starts from residue
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Figure 2.4. Absence of Any Observable Interaction Between CD47-CT and PLIC-2
UBA/UBL Domains. (A) 15N-HSQC of PLIC-2 15N-UBL alone (black) and in the presence
of CD47-CT at a UBL to CD47 ratio of 1:10 in red. (B)

15N-HSQC

of PLIC-2

15N-UBA

alone (black) and in the presence of CD47-CT at a UBA to CD47 ratio of 1:10 in red. (C)
(Top) ITC thermogram of UBL titrated into buffer (black) and into CD47-CT (red). (Bottom)
Integrated heats of the titration after correction for the heat of dilution. (D) (Top) ITC
thermogram of UBA titrated into buffer (black) and into CD47-CT (red). (Bottom)
Integrated heats of the titration after correction for the heat of dilution.
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number 269, no PTMs affect the outcome of our study, validating the biological
significance of our in-vitro analysis.
In order to ascertain whether CD47 interacts with the UBL and/or UBA domains of
PLIC-2, we performed 15N-HSQC titration experiments with 15N-UBL or 15N-UBA. Figures
2.4A and 2.4B present the spectra of the UBL and UBA domains, respectively. Both
remained unperturbed by the addition of the cytoplasmic tail of CD47 (CD47-CT) with no
CSPs or peak broadenings. To reinforce our results, we performed Isothermal Titration
Calorimetric (ITC) experiments where CD47-CT was titrated against the UBL (Figure
2.4C) or UBA domains (Figure 2.4D). The acquired thermograms reflect the heats of
dilution rather than specific enthalpy driven interactions consistent with the lack of binding.
The other pertinent question to this interaction is the proximity of the tail region to
the membrane surface, as in its native receptor state. To identify any interactions at this
interface, we incorporated the CD47-TMCT, containing the last transmembrane helix, into
small D7 nanodiscs [38]. Nanodiscs offer a soluble lipid bilayer system allowing the study
of interactions at the membrane/water interface. We have previously successfully
employed NMR for the study of the TMCT regions of Integrin β3 in nanodiscs [39]. Work
done by Dr. Puthenveetil showed that nanodiscs formation was successful by TEM and
that there was no binding by NMR or ITC with the CD47-TMCT construct, indicating that
the addition of a membrane mimetic does not produce any observable binding between
CD47 and the UBL or UBA domains of PLIC-2.
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Figure 2.5. PLIC-2 Body Region Does not Bind to CD47-TMCT.
CD47 TMCT. (A)

15N-CD47

15N-HSQC

of labeled-

TMCT alone (black) and in the presence of PLIC-2 Body

region at a CD47 to Body ratio of 1:3 in red. The amide peak with a slight intensity drop
in the presence of Body is marked by the asterisk. Inset: Negatively stained TEM
micrograph showing the formation of nanodiscs containing the incorporated

15N

labeled

protein (B) 15N-CD47 TMCT alone (black) and in the presence of PLIC-2 UBL domain at
a CD47 to UBL ratio of 1:5 in red.

2.3.4 – Investigation of the CD47 and PLIC-2 Body Region
Since no interactions were observed between the PLIC-2 UBA/UBL domains and
CD47, we focused our attention on the PLIC-2 Body region. This is a 51.6 kDa intrinsically
disordered protein that would provide a

15N-HSQC

spectrum with a multitude of

overlapping peaks corresponding to random coil frequencies making it difficult to observe
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any CSP or peak broadenings leading to inconclusive and ambiguous data. Therefore,
we tried to analyze this interaction from the side of CD47 by titrating

15N-CD47-TMCT

with unlabeled Body region. We also performed the same experiment with the unlabeled
UBL domain serving as a control; and additionally confirming the above obtained results
for the

15N-UBL

and unlabeled CD47-TMCT experiment. Figure 5 shows the spectra of

15N-CD47-TMCT

alone (black) titrated against unlabeled proteins, Body (Figure 2.5A) and

UBL (Figure 2.5B) shown in red. Both titration resulted in no pronounced changes in
resonance frequencies or peak intensities of CD47. There was however, a slight intensity
drop observed for the amide located at 8.20/116.56 ppm in the presence of the Body
region (marked with the asterisk in Figure 2.5A); but a minor intensity drop for a single
peak does not substantiate a binding interaction between two proteins.
The absence of binding was further confirmed through ITC measurements using
the CD47-CT construct (Figure 2.6). ITC measurements were performed to confirm the
lack of binding from the NMR data between CD47 and PLIC-2 Body region. The initial
titration of the Body region with CD47-CT showed some heat differences that could be
interpreted as a binding curve. However, after careful analysis of the full data set, we
concluded that it wasn’t the case. Our rationale is based on the following arguments.
First, the overall heat differences are low, so the data is close to the measurement limits
and is at the noise level making each single titration unreliable. To overcome this
limitation, we performed two titrations with a constant concentration of CD47-CT as a
titrant into two different concentrations of the PLIC-2 Body protein present inside the
measurement cell. If the observed calorimetric isotherms and the corresponding titration
curves reflect a real binding event, we expect the lower concentration of PLIC-2 to
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Figure 2.6. ITC Confirms the Lack of Interaction Between PLIC-2 Body Region and
CD47. ITC thermograms of CD47-CT titrated into buffer (black) or into PLIC-2 Body
region (red) at two different concentrations of PLIC-2 protein. The normalized fit shows
the heats for both 50µM and 40µM PLIC-2 Body region.
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saturate earlier owing to a lower requirement for a titrant concentration. In fact, we got
opposite results, which indicates the artificial nature of observed curves as the point of
saturation for 50µM of Body came sooner than the one for the 40µM titration. Lastly, if we
forcefully fit the thermogram to obtain a binding constants, the data would place a Kd
value into the low 100 nM range, which is a relatively strong binding affinity and should
be easily detectable by NMR spectral analysis (as we demonstrated earlier for even
weaker PLIC-2 inter domain interactions which were the µM range). Taken together, we
believe that the observed shifts in heat values were likely produced due to proteins
aggregation during titration, manifested by acquired samples cloudiness visible upon
experiments completion.

2.3.5 – Does PLIC-2 Directly Associate with CD47?
The evidence presented here clearly indicates that PLIC-2 does not associate with
CD47 in vitro. Though it seems to contradict the report from Wu and colleagues [11], the
inference that the two may not be directly associated is not inconceivable when we factor
in the following reasons. It is important to keep in mind that the work done here is
performed on isolated domains of PLIC-2 (UBA, UBL, and Body region), where the full
length protein may adopt an overall fold necessary for interacting. For instance, the
UBA/UBL self association may be fairly weak as presented here (K d = 175±25 µM), but
there is evidence of PLIC-2 forming dimers/trimers [40] possibly through the Body region
[41] , which may promote intermolecular UBA/UBL association.
Furthermore, it is probable that CD47 and PLIC-2 are part of a larger
macromolecular assembly that may also contain, for example, integrin heterodimers [42].
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The sole in vitro data available for PLIC’s interaction is from a pull down assay using
recombinant GST-fused PLIC probed against CD47 from human placenta and analyzed
through immunoblots [11]. This doesn’t rule out the presence of other proteins that could
have been part of the pull down result and hence doesn’t exclude the possibility that other
protein(s) might be involved in the complex formation. Silver staining of the pull down
eluate followed by subsequent LC-MS might help identify these components. Since this
experiment was not performed in the original study, the direct interaction of CD47 to PLIC
remains a conjecture.
On the other hand, there is a possibility that PLIC-2’s role may not be a cytoskeletal
adaptor protein at all, but rather serves an entirely different function altogether. Several
studies have shown the involvement of PLICs in alternative cellular processes, such as
proteasomal degradation [27, 43], GPCR endocytosis [24], clathrin mediated endocytosis
through Eps15 and and Epsin (1 and 2) [24], and evidence in this chapter indicating that
it is able to bind to ubiquitin. To complete the picture, recent evidence has arisen
illustrating the functional role of the Body region, which had been elusive thus far as there
was no established binding partner despite being predicted to contain six STI1 heat shock
binding motifs. A recent study by Hjerpe and colleagues has implicated the Body region
to associate with heat shock protein 70 (HSP70) whom is bound to an aggregated client
protein. The entire complex (PLIC-2/HSP70/Target protein) is then transferred to the
proteasomal complex for degradation. Specific mutations linked to amyotrophic lateral
sclerosis located within the Body region were shown to abolish PLIC-2/HSP70 complex
formation [40], highlighting the significance of recycling protein aggregates. The data
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suggests that the Body region is responsible for payload transfer and potentially substrate
recognition, further consolidating PLIC-2’s role as a proteasomal shuttle factor.

2.4 – Conclusion
Even though we employed high sensitivity/ high-resolution biophysical techniques,
we did not observe direct interactions between the cytoplasmic tail of CD47 and any of
the individual domains of PLIC-2. Both ITC and NMR results consistently refute the notion
of a binary complex. Though it is possible that the conditions for our in vitro analysis may
not have been ideal, the evidence of UBA/UBL self association and UBA/Ubiquitin
complex formation coincides with the current literature showing that PLIC-2 belongs to
the proteasomal degradation pathway. This raises questions against its involvement as a
protein linking the membrane to the cytoskeleton and leaves one to ponder whether the
name Ubiquilins should be preferred over PLIC while referring to these adaptor proteins.
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Chapter 3 – Investigating the Role of the
Juxtamembrane Region of BTN3A1 in Ligand
Induced Activation
Adapted from: Nguyen, K., Li, J., Puthenveetil, R., Lin, X., Poe, M., Hsiao, C.C.,
Vinogradova, O., and Wiemer, A. The butyrophilin 3A1 intracellular domain undergoes a
conformational change involving the juxtamembrane region, FASEB J., just accepted.

3.1 – Introduction
3.1.1 – Butyrophilins, Phosphoantigens, and the Immune Response
The butyrophilins (BTN) are type I receptor glycoproteins with further classification
as BTN1 (A1), BTN2 (A1, A2, A3), and BTN3 (A1, A2, A3) subfamilies [1]. They possess
diverse functionalities as BTN1 is involved in the milk secretion during lactation whereas
BTN2 and BTN3 were found to be able to activate/inhibit the immune system [1, 2]. In
particularly, BTN3A1 has been the focus of attention due to recent studies have
identifying it to be essential for the activation of Vγ9Vδ2 T cells [3-5]. These T cells, upon
activation, respond by quickly lysing the target cells by generating pro-inflammatory
cytokines [6, 7]. Given the clinical potential to use this mechanism as a means for the
removal of cancerous entities, it is imperative to understand the activation mechanism of
BTN3A1 and how it eventually translates to the activation of Vγ9Vδ2 T cells.
BTN3A1 is a ~54kDa protein, after removal of the signal peptide, that contains two
extracellular Ig domains (IgC and IgV), a single transmembrane helix, an intracellular
B30.2 domain, and a stretch of 68 amino acids, denoted as the juxtamembrane (JM)
region, between the transmembrane helix and B30.2 domain (Figure 3.1). BTN3A1 is
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Figure 3.1. Representation of BTN3A1 and Diphosphates. In (A), a simplistic diagram
of BTN3A1 is shown to better visualize its domains and positioning of domains, where
IgV and IgC domains reside in the extracellular region, a single transmembrane helix, and
the intracellular JM region and B30.2 domain. Since the focus is on the intracellular
region, the structure of B30.2 bound to cHDMAPP (PDB ID: 47NU) while showing the
nearby positively charged residues. The JM region is not structurally characterized, but
models (calculated through I-TASSER [24] (model 1) or MODELLER (model 2) [23]) show
that a potential for a highly helical features. (B) shows the ligands used within this chapter
as well as cHDMAPP, which was used in the crystal structure [14]. It is important to note
that the nomenclature can be inconsistent at times in the literature as HMBPP can also
be referred to as HDMAPP, which more clearly shows its relation to cHDMAPP and
DMAPP.
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activated upon association with phosphoantigens (pAg), who are small molecules that
possess a diphosphate moiety. The B30.2 domain possesses a strong affinity for (E)-4hydroxy-3-methyl-but-2-enyl diphosphate (HMBPP), where its Kd is ~2 µM [8].
Interestingly, HMBPP is a natural product that is known to be synthesized in bacteria, but
not in humans, through the non-mevalonate pathway as a precursor for the formation of
isopentyl disphosphate (IPP) [9], who has a ~71000 fold weaker EC50 than HMBPP for
the expansion of Vγ9Vδ2 T cells [8]. This highlights the potential for targeting BTN3A1 as
its activity depends on exogenous compounds and that not all disphosphate containing
compounds readily activate BTN3A1, sparking the interest for synthesizing HMBPPderviatives and prodrugs [8, 10, 11] or drugs that stimulate pAg accumulation [12, 13].

3.1.2 – The Binding Pocket and BTN3A1 Activation
Given that the drug target and ligand is known, Sandstrom and colleagues
provided a crystal structure of the B30.2 domain in its apo (PDB ID:4N7I) and bound (PDB
ID: 4N7U) state [14]. The bound state was crystallized through the use of a HMBPPderivative, hydroxy-methyl-butyl-pyrophosphonate (cHDMAPP), that was chemically
crosslinked through the use of glyceraldehyde. The B30.2 domain contains two β-sheets
within its core with a positively charged shallow binding pocket for cHDMAPP (Figure 3.1),
where mutations that reversed the charge (H351R) abrogates pAg association. Though
it appears to be clear that the binding pocket resides on the B30.2 domain of BTN3A1, a
comparison of the apo and bound form illustrates the lack of a conformational change
upon ligand association. This is a bit troubling as it does not provide additional insight in
the possible activation mechanism of BTN3A1.
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BTN3A1 activity could be related to its association with protein partners. For
instance, periplakin has been found to be relevant in the activation of Vγ9Vδ2 T cells [15],
which is predicted to be due to the direct association to the JM region, as well as RhoB,
whose association with BTN3A1 is weakened if HMBPP is present [16]. However, there
is little detail of the binding interfaces and how exactly HMBPP could influence proteinprotein interactions.
To examine this conundrum, a previous report by Hsiao and colleagues had
investigated if there was a difference between the BFI (construct contains the JM and
B30.2 domain) and the B30.2 domain upon interacting with HMBPP [8]. Though the ITC
results reported indicated that the Kd and ΔH values were similar between the two
constructs, the NMR spectra had shown remarkable differences in chemical shifts for the
BFI/HMBPP titration that were not observed for the B30.2/HMBPP titration. Given that the
difference between the two constructs is the presence of the JM region, it can be
postulated that the JM region is involved in some way with ligand association. This is an
important clue to understanding how BTN3A1 may be activated as the large chemical
shift differences could be indicative of a conformational change that encompasses the JM
region. Therefore, the work presented here will investigate the role of the JM region in
HMBPP-induced activation.

3.2 - Materials and Methods
Protein Purification
Following sequencing, all the recombinant clones were transformed into E.coli BL21 (DE3) cells and grown on an agar plate with antibiotics specific to the vector. A single
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colony was transferred to LB broth and grown overnight at 37 °C to be transferred to LB
or M9 minimal media. For M9 minimal media, 15NH4Cl and/or 13C-glucose were added as
the sole sources of nitrogen and carbon. Cells were induced with 1 mM isopropyl β-D-1thiogalactopyranoside once they reached an optical density of 0.5 and harvested after 4
hours.
The JM region was purified under denaturing conditions from recombinant
expression within inclusion bodies. A base buffer containing 8 M urea, 100 mM Tris, and
200 mM NaCl at pH 7.4 was used. Cells were resuspended in lysis buffer (base buffer +
5 mM imidazole) and lysed by three passages through French Press (Thermo Electron,
USA). The lysate was centrifuged at 12,000 rpm. Supernatant containing the denatured
protein was mixed with Ni-NTA resin (Qiagen, USA) at room temperature for 2 hours. The
resin was washed with 10 mM imidazole and eluted with 300 mM imidazole in base buffer.
The eluate was loaded onto a Proto 300 C4 column (Higgins Analytical Inc., USA) and
purified in a 10-40% gradient formed by buffer A (90% H2O, 10% acetonitrile, 0.1%
trifluoroacetic acid) and buffer B (90% acetonitrile, 10% H2O, 0.1% trifluoroacetic acid).
Protein fractions were collected and lyophilized for later use. SDS-PAGE analysis was
performed to analyze the purity of the purified protein.

Nuclear Magnetic Resonance Spectroscopy
All NMR experiments were performed on a Varian INOVA 600 MHz spectrometer
(Agilent, USA) at 25oC. Protein-protein interaction studies were carried out through 1H15N

HSQC experiments collected using 2048*128 increments. The interaction between

JM and HMBPP, DMAPP, GDP, and sodium diphosphate was accessed in buffer
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containing 100 mM MES, 50 mM NaCl, 5 mM BME, and 8% D 2O at pH 6.5. HMBPP,
DMAPP, GDP, and sodium diphosphate was added in a molar excess of 10 times the
concentration of the JM region protein.
Spectra for backbone assignments (HNCACB, HNCA, HN(CO)CA, CBCA(CO)NH)
were collected using 1024*32*16 increments in the direct, carbon, and nitrogen
dimensions, respectively. HNCO experiments were executed with lower increments in the
carbon dimension (ni = 16). Experiments were performed in the presence of 5 mM
dodecylphosphocholine (Avanti Polar, USA). Peak peaking was performed using CcpNmr
software suite [17] and chemical shifts of assigned peaks were used to predict protein
secondary structure through the TALOS+ webserver [18].

3.3 – Results and Discussion
3.3.1 – HMBPP Induced Conformational Change
Previously, published work [8] provided evidence that the JM region was affected
in some way after the addition of HMBPP when you compare the bound B30.2 and BFI
15N-HSQC

spectra. This was a novel discovery due to the fact that it currently is unknown

as to how HMBPP binding leads to the activation of BTN3A1. Given that HMBPP affects
the JM region as well, it was postulated that ligand binding induces a conformational
change within the intracellular region of BTN3A1.
To confirm that this does occur, SAXS (done by Dr. Puthenveetil) was used to
visualize the surface envelope of BFI in the presence and absence of HMBPP as shown
in Figure 3.2. Both BFI and BFI/HMBPP exhibit globular shapes, indicating that the JM
region is likely to be unstructured rather than a rigid α-helix. When we compare the
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Figure 3.2. The BTN3A1 Intracellular Domain is a Globular Structure that is
Compacted upon HMBPP Binding. (A) Schematic representation of the rearrangement
of the BFI region (JM+B30.2 domain) in the presence of HMBPP. (B) Scattering curve for
BFI in the presence (blue) or absence (green) of HMBPP and overlay of the normalized
pair-distance distribution curves P(r) of the scattering curves. (C) Surface representation
of the average ab initio model for BFI and BFI+HMBPP rendered through SITUS [25],
where the JM is colored separately in red. The dotted lines represent the missing residues
between the JM and B30.2 in our model.

differences between the two surface envelopes, we see that the addition of HMBPP
causes a reduction in the radius of gyration (Rg) by ~ 2Å and Dmax by ~8 Å. This reduction
can be characterized as BFI compacting upon ligand association, which provides
evidence that a conformational change does occur. Since SAXS only provides a low
resolution envelope, it is difficult to define the molecular details of the conformational
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change. However, we hypothesized that HMBPP binding to B30.2 leads to a reorientation
of the JM/B30.2 as visualized in Figure 3.2A and 3.2C.
This hypothesis was also based on the crystal structure of the apo and bound
form of B30.2 obtained by Sandstrom and colleagues [14]. The calculated backbone
RMSDs between the apo and complexed B30.2 (4N7I vs. 4N7U) was 0.094Å by matching
amide nitrogens using Chimera [19], which is negligible. As a result, ligand binding
appears to have minimal or no affect on the overall structure of the B30.2 domain. Thus,
we predict that the conformational change is related to the relative orientation of the B30.2
and JM region. However, one caveat is that the crystal structure was crosslinked with the
ligand, implicating that it may not properly depict the true bound state of B30.2. It is then
not possible to completely rule out that the B30.2 can undergo its own conformational
changes in combination with the JM.

3.3.2 – Juxtamembrane and Diphosphates
To properly evaluate the molecular details of this conformational change, we opted
to utilize an NMR approach. However, evaluation of the JM region within the BFI construct
was not feasible due to serious spectral overlap. To circumvent these difficulties, we have
chosen here to investigate the JM region directly and therefore we cloned the isolated
BTN3A1 JM region consisting of 68 amino acid residues at position 272-339. Though we
planned on studying the interaction between the isolated JM region and B30.2 domain
constructs, the pH requirements for solubility of the constructs appeared to be
incompatible. This led to a high propensity of the two domains to precipitate upon mixing
under any buffer conditions we tested.
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Therefore, we opted to test whether the JM region could directly associate with
HMBPP as an avenue for facilitating the conformational change. We have found that the
majority of JM amides in

15N-HSQC

spectrum are sharp and lay within the range of

random coil chemical shifts values (8.5 -7.5 ppm), reflecting predominantly unstructured
ensemble of conformers in a fast exchange. Several peaks are broader though, indicating
an exchange getting to the intermediate range. As the binding is expected to be weak
due to the absence of the B30.2 domain, HMBPP was titrated in at a 10 fold excess.
Comparison of the JM region alone and the JM region with HMBPP shows that there are
spectral differences and that the differences are not drastic, implicating that HMBPP
associates weakly to the JM region (Figure 3.3A). The major effects are characterized by
differences in line shape, such as peak sharpening, rather than chemical shift
perturbations (Figure 3.4), suggesting a very dynamic nature of the ensemble of
conformers in exchange. One affected amide, marked by the asterisk in Figure 3.3A and
located within the region where serine/ threonine residues are usually found, indicates
that HMBPP binding promotes one particular conformation for this amino acid from
several potential conformations in intermediate exchange.
Since HMBPP was able to bind to the JM region, we sought to determine the
appropriate functional group responsible for interacting. For this, we tested the effect of
DMAPP, a molecule whose chemical structure is identical to HMBPP barring the absence
of the allylic alcohol (Figure 3.1B). We found that DMAPP interacts with the JM region
with a very similar pattern of chemical shift perturbations (Figure 3.3B) as HMBPP,
indicating that the allylic alcohol is nonessential for the interaction. Interestingly, the JM
region also weakly associated with GDP and sodium diphosphate (Figure 3.3C/D), two
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Figure 3.3. The JM Region Interacts with Various Diphosphates. (A) HSQC of JM
alone and with HMBPP at a 1:10 ratio. There are minor differences as marked by the
asterisks, signifying that HMBPP weakly associates with JM. The overall effect of binding
is nearly identical for (B) JM:DMAPP, which implies that the hydroxyl of HMBPP is
nonessential for binding. 15N-HSQC titrations of JM with GDP (C) or sodium diphosphate
(D) at a 1:10 ratio show similar differences as marked by the asterisks, which shows that
GDP and sodium diphosphate are able to interact with the JM region similarly to HMBPP.
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Figure 3.4. Quantification of Peak Lineshape Changes. (A) 15N-HSQC that shows all
resonances for JM WT in the absence of DPC. No assignments were done, but peak
numbers are shown to better visualize the peaks evaluated in (B) and (C). In (B) and (C),
a compound graph shows normalized linewidth in relation with the peak intensity of the
JM alone in the absence of DPC. Peaks with minimal or no overlap were selected and
were ordered based on their peak intensity, where peaks 1, 2, and 6 correspond to
S303/T304 and peaks 5 and 7 correspond with S296/T297. Quantification was performed
by analyzing spectra generated without the use of apodization functions. The line width
of the 1H and 15N were averaged (𝜈𝑎𝑣𝑒 = √

2 +𝜈 2
𝜈𝐻
𝑁

2

) first and then normalized by setting the

averaged linewidth of JM only to 100 for individual peaks. (B) shows the linewidth
difference upon addition of HMBPP and the standard deviation is shown (n=2), whereas
(C) is with DMAPP, GDP, or diphosphate.
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diphosphates that do not activate BTN3A1. Similarly, the effects on peak shape were
consistent between all ligands tested (Figure 3.4). Given the common functional groups
of these ligands is the negatively charged diphosphate, this suggests that the diphosphate
moiety participates in the interaction with the JM region while the allylic alcohol, which is
necessary for high potency interactions, likely binds to the B30.2 binding pocket rather
than the JM region.
However, the interactions we observed by NMR are weak with minimal spectral
changes. To further confirm that the diphosphate is associating with the JM region, Dr.
Poe performed competitive binding assays by ITC (Table 3.1) using the BFI and B30.2
constructs as the binding affinity of HMBPP to the isolated JM region is too weak for
competitive binding. The addition of 100x molar excess of sodium diphosphate to BFI was
able to reduce the ΔH from -53.7 kJ/mol to -32.9 kJ/mol while becoming more entropically
favorable as TΔS increased from -21.6 kJ/mol to -1.1 kJ/mol, suggesting that diphosphate
alone is able to competitively bind to BFI. In comparison, the addition of 100x molar
excess of sodium diphosphate to B30.2 showed a less pronounced change in the ΔH
(from -53.7 kJ/mol to -38.4 kJ/mol) and ΔS values (from -23.0 kJ/mol to -7.7 kJ/mol).
Though modest, the effect of the diphosphate is lessened in the absence of the JM region,
which indirectly substantiates that the JM is involved in the interaction with the
diphosphate.
Table 3.1. Summary of the Thermodynamic Data Derived from ITC Measurements
Under Different Conditions.
ΔH (kJ/mol) TΔS (kJ/mol) Kd (µM)
BFI
-53.7
-21.6
2.36
BFI + Diphosphate
-32.9
-1.1
2.61
B30.2
-53.7
-23.0
4.27
B30.2 + Diphosphate
-38.4
-7.7
4.10
Sample
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n
0.845
0.860
0.994
1.070
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Thus, the model that we envisioned was that HMBPP could potentially interact with
the JM region as well. This notion is also consistent with the B30.2/C-HMBPP crystal
structure because a closer look at the electron density of the bound ligand only shows a
well-defined tetrahedral moiety suitable for fitting the β-phosphate functional group. This
suggests that the other portion of HMBPP was flexible as it was not visualized by x-ray
crystallography [14]. This could be due to non-optimal cross-linked conformation of the
apo B30.2 used for crystallization as discussed above, which was not able to promote
additional contacts, such as with H381 or other nearby residues [20], including the ones
from JM region. Our data suggests that the JM region may coordinate with the second
exposed phosphate given that DMAPP, which lacks the allylic alcohol, GDP and even
simple diphosphate still show the same weak association with the JM region.

3.3.3 – NMR of the JM Region in the Presence of DPC Micelles
Since the JM was determined to interact with diphosphates and this could
potentially key for the activation of BTN3A1, we needed to further characterize the
molecular details of this interaction. Given that we have been performing NMR
experiments, the logical step would be to perform 3D experiments and assign the
backbone amide resonances. However, the JM region is sparingly soluble and has a
tendency to aggregate, leading to inadequate quality necessary for 3D experiments. To
improve protein solubility and stability, we performed backbone assignments of the JM
region in the presence of dodecylphosphocholine (DPC) micelles (Figure 3.5). The quality
of the spectrum was greatly improved as witnessed by the increased signal to noise ratio.
Unfortunately, the degeneracy of the JM region’s primary sequence due to the large
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Figure 3.5. DPC Enhances Stability and Solubility to Allow for Partial Assignments.
(A) 15N-HSQC that shows all resonances for JM WT in the absence of DPC. (B) 15NHSQC of JM Wild Type in the presence of 5mM dodecylphosphocholine. Partial
assignments of the protein were done and assignments are shown. For T297 and T304,
conclusive assignments were not possible, but two peaks are labeled with a high
probability of being a threonine. The secondary structure was predicted from the chemical
shifts of the assigned residues using TALOS+ and is shown in (C).
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Figure 3.6. Scheme for Sequential Assignments by Matching Resonances.
Illustration of the scheme behind backbone assignments, where sequential amino acids
can be determined by the alignment of the Cα and Cβ shifts. The experiments provide
shifts for the residue itself (i) and the previous residue (i-1). The above shows multiple
strips of different

15N

chemical shift from HNCACB and HNCA experiments, where

alignments are shown by dotted lines.
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number of sequentially repeated amino acids (QQQEEKK, RKKKR, etc.) combined with
the low solubility and conformational heterogeneity made it difficult to fully complete the
resonance assignments. An example of the sequential assignments is shown in Figure
3.6, where the alignment of the Cα and Cβ chemical shifts determined the string of amino
acids.
From the partial assignments (as marked in Figure 3.5B), we were still able to
predict the secondary structure of the JM region, which shows that the C-terminus is
highly helical and the N-terminus begins as a random coil (Figure 3.5C). Though the
central region was not adequately assigned, the disparity of the proton shifts falls within
a narrow region around ~8.2 ppm, indicating that it is likely that it is predominantly random
coil. This is substantiated by our SAXS data that shows the probability of a dimeric coiledcoil structure is minimal, at least in the absence of the transmembrane linker. Also, the
repeated HxxHCxC motif or a tryptophan/leucine zipper, which is typical of dimeric coiled
coils, is not found in the JM sequence. This is strikingly different than most prediction
servers, where it predicts that the JM is highly helical and forms a coiled coil structure
[21-24]. However, it is also possible that the JM region could become helical upon ligand
binding, especially due to the conformational change relative to the B30.2 domain.
However, this could not be experimentally validated due to the buffer incompatibilities of
the isolated B30.2 and JM region.
With the partial backbone assignments, we hoped that it would cover residues that
were perturbed upon HMBPP association. We have tested whether the JM region
interacts with HMBPP in the presence of detergent mimicking membrane-water interface
and found that zwitterionic DPC competes with negatively charged diphosphate ligands
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Figure 3.7. HMBPP is Able to Interact with the JM at Low Concentrations of DPC.
15N-HSQC

of the JM region in the presence of DPC at a ratio of 1:40 (A) and 1:120 (B).

HMBPP was titrated in at a 1:10 ratio. Minor line broadening is observed in (A) as marked
by the asterisk while no significant differences is seen in (B) when the DPC ratio is much
higher.
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for JM binding in a concentration dependent manner. At a low JM:DPC ratio (1:40),
several peaks broaden upon addition of HMBPP, indicative of binding, whereas a higher
ratio (1:120) showed no significant changes due to the saturation of one peptide molecule
per micelle (Figure 3.7). Based on the low JM:DPC ratio, we focused on identifying the
residues involved with interacting with HMBPP. Despite the fact that these amino acids
could not be conclusively assigned, unique chemical shifts indicated that at least one
threonine residue was involved. The JM construct contained only three threonine residues
(at positions 279, 297 and 304). Since T279 was assigned, the partial residue
assignments narrowed down the HMBPP binding to the JM region to occur at one of these
two positions. This also coincides well with the JM data in the absence of DPC, which
shows

perturbation

of

peaks

within

the

spectral

region

that

is

generally

serines/theronines. Thus, we focused our efforts on mutation of the three non-conserved
amino acid residues found in these two ST sequences and generated a ST296AA mutation
and a T304A mutation.

3.3.4 – Investigation if JM Mutants Associate with HMBPP
To further confirm our conclusions from NMR data hampered by partial
assignments, we investigated JM point mutants to uncover if those two threonines had a
functional role. As shown in Figure 3.8, both mutations clearly altered the NMR spectrum
in the expected region as alanine mutations would greatly affect the chemical shift of the
residue mutated and sequential amino acids. By looking for peaks that are greatly shifted,
we identified peaks correlating with S296, T297, S303, and T304. Interestingly, the point
mutations lead to pronounced chemical shift changes beyond sequentially adjacent
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Figure 3.8. Specific Mutations Perturb the JM Threonine Spectra and Inhibit HMBPP
Interaction.

15N-HSQC

comparison of JM and (A) its ST296AA mutant or (B) its T304A

mutant. Based on the chemical shift changes, peaks corresponding to the mutated
serine/threonine residues were identified, where solid lines represent confident
assignment and dashed lines are slightly ambiguous. The mutations affect multiple peaks,
suggesting that these point mutations affect the local structure. HMBPP was titrated into
the mutants at a 10:1 HMBPP:JM ratio, but no interaction was seen for (C) ST296AA or
(D) T304A.
54

Chapter 3 – Investigating the Role of the Juxtamembrane Region of BTN3A1 in Ligand Induced Activation

residues, suggesting that there may be some local structure within the JM region as it
affects residues through space rather than through bond.
We assessed whether HMBPP was able to interact with the JM mutants and found
that there was essentially no difference between the

15N-HSQC

of each mutant in the

presence and absence of HMBPP. Thus, we concluded that there is no association of
HMBPP to the JM mutants, meaning that both threonine residues are important for
HMBPP binding to the JM region.

3.3.5 – Correlation of NMR data with In Vivo Experiments
Though the evidence so far shows that JM likely interacts with the diphosphate
moiety, the interaction is fairly weak and it requires further investigation to properly
confirm its functional significance. For this, we looked at the effect of the threonine
mutants in vivo on the activity of BTN3A1. Cellular assays using K562 cells and interferonγ quantification, performed by Jin Li, had shown that the mutants were able to reduce the
EC50 of HMBPP from 0.056 µM (WT BTN3A1) to 3.1 µM and 3.8 µM for ST296AA and
T304A mutants, respectively. The effect was statistically significant and was validated
against control experiments (BTN3A1 surface expression levels, BTN3A1 knockout
negative control, BTN3A1 knockout + WT transfected control). The activity of the mutants
fell between the activity levels of the WT BTN3A1 and BTN3A1 KO, providing evidence
that the threonines do serve a functional role in vivo.
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3.3.6 – A Binding Model
Based on the SAXS, NMR, and ITC, it is clear that a conformational change occurs
and that the JM is involved. The relevance of this interaction is further elevated based on
the cellular assays, which showed that the mutants ST 296AA and T304A showed a
statistically significant reduction in BTN3A1 activity, validating that the JM region is
essential for Vγ9Vδ2 T activation. Thus, the binding model that we hypothesized based
on these findings (presented in Figure 3.2A) shows that the binding of HMBPP to B30.2
is likely to cause a conformational change in the orientation of the B30.2 and the JM
region. Once the B30.2 and JM region come in close proximity, the exposed phosphate
group could potentially interact with the JM region to form a B30.2/HMBPP/JM clamp.
Our NMR data shows that one threonine (T304) is more affected, indicating that this is
likely close to the binding pocket. The role of ST296/7, on the other hand, could lie in its
ability to stabilize some local fold and/or its involvement in forming a binding interface with
B30.2.
Nonetheless, the two threonine mutations resulted in the reduced activity of
BTN3A1, emphasizing that the induced conformational change was a key step towards
the activation of Vγ9Vδ2 T cells. The results point towards two possibilities that could
ensue. First, the conformational change within the intracellular domain could transverse
to the extracellular domain, leading to its recognition by T cells. This is consistent with the
conclusions from a recent report where FRET approach was used to show that
bisphosphonate treatment alters the extracellular conformation of BTN3A1 [16]. Second,
the conformational change could lead to the recruitment and/or dissociation of
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intracellular binding partners, for example, RhoB [16] or periplakin [15], eventually
facilitating T cell activation.

3.4 – Conclusion
To conclude, our studies indicate the importance of the BTN3A1 JM region for the
interaction with isoprenoid diphosphates and how its activated state is induced by ligand
binding. Evidence points to the involvement of threonine residues T297 and T304, which
was shown to be relevant in both in vitro and in vivo studies. Though further work will
need to be done to completely understand the molecular details and interface of this
interaction, it will be interesting to find out how the structural changes can impact the
functions of BTN3A1, especially in regards to the full length BTN3A1. Though we present
here the analysis of conformational changes within the intracellular domain, it remains to
be seen how the effects propagate across membranes and to the extracellular surface.
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Chapter 4 – NMR as a Semi-Quantitative Tool for
the Evaluation of Surface Hydrophobicity

4.1 – Introduction
4.1.1 – Proteins in the Industry
Though proteins are essential components naturally produced and regulated
within our body, there has been increasing interesting in the development of biologics for
medicinal purposes. When we deal with these proteins in the industrial setting, there is a
large focus on the overall stability of the protein, considering that they would be subjected
to a number of hostile environments during processing. One of the major setbacks of
protein formulations is the stability, which includes the propensity of the protein to unfold
and/or aggregate [1]. This scenario has been observed with antibodies [2], which is
unfortunate because of the high monetary cost and safety concerns associated with
antibodies [3, 4].
The stability of a protein is a difficult parameter to assess and predict, but one key
component is its hydrophobicity. Hydrophobicity has been accepted to be vital for the
folding of proteins, where the hydrophobic effect leads to the internalization of nonpolar
residues [5, 6], as well as protein-protein interactions between hydrophobic patches on
the surface of the protein [7-9]. However, surface hydrophobicity is also responsible for
nonspecific protein interactions, leading to protein aggregation, protein self-association,
and surface adherence [1, 10-12]. Though hydrophobic interactions are not the sole
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driving force for protein interactions, understanding this phenomenon would be beneficial
in early determination if a protein would be likely to be stable.

4.1.2 – Methods for Quantification of Protein Hydrophobicity
In order to properly understand the role of hydrophobicity in the overall behavior of
the protein, it becomes essential to quantify its hydrophobic character. This can be
classified to be as the net hydrophobicity, which accounts for all nonpolar side chains
present, or the surface hydrophobicity, which only deals with the solvent exposed
nonpolar side chains [13, 14]. Though they are both important, surface hydrophobic is a
major contributor to physical instabilities, such as protein self-association, aggregation,
and adsorption to interfaces [1, 15, 16]. Therefore, focusing specifically on quantification
of the surface hydrophobicity would be ideal for which different experimental techniques
have been used.
Hydrophobic Interaction Chromatography (HIC) is a purification method that has
relatively mild solution conditions compared to other chromatographic techniques such
as Reverse Phase Chromatography [17-19]. In HIC, the proteins bind to a stationary
phase composed of a nonpolar hydrocarbon chain. The mobile phase consists of a high
concentration salt, such as ammonium sulfate, in order to promote protein/column
association. As the salt concentration is gradually decreased, the proteins will begin to
elute off the column in the order of their hydrophobicity, where the least hydrophobic
protein would elute first. As a result, it is possible to compare the surface hydrophobicity
of proteins.

61

Chapter 4 – NMR as a Semi-Quantitative Tool for the Evaluation of Surface Hydrophobicity

Unfortunately, there are caveats associated with HIC that should be considered.
The strength of the protein’s association with the column is highly dependent on the
experimental conditions, such as temperature, salt, and ionic strength of the mobile
phase, which could considerably change the retention times of the proteins [19-23]. This
makes it particularly difficult to compare hydrophobicities of proteins unless the
experimental conditions are identical. The protein is also subjected to a fairly high ionic
strength of salt buffer, which could screen electrostatic interactions, meaning that it may
be an untrue representation of the hydrophobic characteristics of the protein as a whole.
It is important to keep in mind that HIC solution conditions are not equivalent to
formulation and storage buffers.
Another method is the use of extrinsic fluorescence probes, such as ANS, Bis
ANS, and Prodan. This method works because these probes have differing properties in
an aqueous or hydrophobic environment. In the aqueous environment, the probes have
a low quantum yield. When the probes are in a hydrophobic environment, the quantum
yield is much higher and the wavelength of maximum fluorescence shifts [24]. Therefore,
it is possible to deduce when the probes bind to hydrophobic patches on the protein by
monitoring the change in fluorescence. Although this method is simple, fast, and
nondestructive, there are some concerns in regards to its reliability. The overall structure
of the extrinsic dyes is quite diverse, where they can vary in size as well as aromatic,
aliphatic, and charged functionalities. As a result, the mode of binding can be different
between dyes, ultimately leading to differences in hydrophobicity values [25]. This is
particularly important when we consider that charge-charge interactions may occur in
some cases like the charged dye ANS, which could enhance or reduce its overall binding
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affinity to the protein, influencing its estimation of hydrophobicity [17, 26]. As a result, the
quantification of surface hydrophobicity may not be entirely accurate.
To conclude, both traditional techniques, fluorescence spectroscopy and
hydrophobic interaction chromatography, have a number of experimental problems
limiting their ability to provide an accurate value of hydrophobicity. Even then, the
techniques only determine relative hydrophobicities, which do not provide any significant
information of the protein’s hydrophobic character unless compared to another protein.
Therefore, this stresses the importance of establishing a multi-method quantitative
measurement protocol to define surface hydrophobicity.
The alternative method that we will explore is the use of NMR to determine the
surface hydrophobicity of proteins. NMR is a sensitive and robust technique that can be
used to study the binding between a small molecule (probe) and a larger macromolecule
(protein) by observing the transverse relaxation time (T2) [27]. Though the concept is not
novel considering that drug screening by NMR has been a common approach for drug
design, where fragment based drug design focuses on finding small molecule binders in
specific locations on the protein [28], the investigation proposed here has a novel
application by studying the interactions of small hydrophobic probes to proteins. The idea
is to use an excess amount of small molecular probe, which would allow it to
nonspecifically bind to many different locations of the protein. By selectively using
hydrophobic probes, we can then deduce the overall surface hydrophobicity of the protein
by analyzing the extent of binding. The benefit of using NMR is that we would be able to
conduct experiments in buffers matching formulation and storage conditions (unlike HIC)
while being unrestricted to the use of only aromatic probes (unlike fluorescence).
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In this study, the sensitivity of NMR to measure surface hydrophobicity was
explored by comparing the extent of binding between various probes and protein
standards. The probes utilized were chosen based on the aliphatic or aromatic features.
The results determined by NMR would be corroborated with HIC and fluorescence to
further substantiate our findings.

4.2 – Materials and Methods
Materials
Bovine Serum Albumin (BSA), α-Chymotrypsinogen A from Bovine Pancreas (AChytA), and β-Lactoglobulin A (B-LgA) from Bovine Milk, N-Acetyl-L-Leucine Methyl Ester
and N-Acetyl-L-Phenylalanine Ethyl Ester were purchased from Sigma (St. Louis, Mo).
Acetyl-Valine-Methyl Ester was purchased from Bachem Americas Inc., N-Acetyl-Ltryptophan Ethyl Ester was purchased from TCI Chemicals and N-Acetyl-L-Tyrosine Ethyl
Ester was purchased from MP Biomedicals, LLC. ANS (8-anilino-1-naphthalenesulfonic
acid) was purchased from Molecular Probes. The Hiscreen Butyl HP column and
Hiscreen Phenyl HP column was purchased from GE Healthcare. Solutions were
prepared in a sonicated 15 mM ionic strength (8.5 buffer strength) phosphate buffer (pH
7.0). All buffers and protein stock solutions were filtered through 0.22 μm filters.

Sample Preparation
All samples were prepared in the same buffer (8.5 mM sodium phosphate, 15mM
ionic strength, pH 7.0, and ~90% D2O) using nitrogen flushed D2O. The probe
concentration was held constant at 3 mM, where molar ratios of 1:20, 1:50, 1:100, 1:150,
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1:200, 1:400, and 1:1000 correspond to 150 µM, 60 µM, 30 µM, 20 µM, 15 µM, 7.5 µM,
and 3 µM of protein (BSA, A-ChytA, or B-LgA), respectively. A 1:50 ratio was used (1.5
mM probe and 30 µM protein) for comparative studies between probes. The probes were
also investigated alone at the concentrations of 1.5 mM, 3 mM, or 6 mM. None of the
samples contained any reference compounds due to initial observations that internal
references can also bind to the protein targets, which skew the measurements, while
external references significantly complicated the acquisition process due to the problems
associated with shimming of two different compartments simultaneously.
The probes selected to be tested belong to two major subclasses of compounds:
aliphatics and aromatics. The aliphatics consisted of tert-butyl alcohol, 1-propanol, and 1butanol whereas only phenol was used as an aromatic. In addition, capped amino acids
were selected to mimic protein-protein interactions. Similarly, the capped amino acids
were chosen based on their aliphatic and aromatic side chains, with the aliphatics being
N-acetyl-L-leucine methyl ester, and N-acetyl-L-valine methyl ester, and the aromatics
were N-acetyl-L-phenylalanine ethyl ester, N-acetyl-L-tryptophan ethyl ester, and Nacetyl-L-tyrosine ethyl ester.

Measuring Transverse Relaxation Time
The binding of the probe to the protein was determined by measuring the
transverse relaxation time (T2) of the probe. Samples were prepared in 535-PP-7 NMR
tubes purchased from Wilmad Labglass (Vineland, NJ) and experiments were performed
at 25 °C. The water signal was suppressed by presaturation at power level of 6 dB for 3
seconds. The T2 was acquired from array experiments performed by using the Carr-
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Purcell-Meiboom-Gill (CPMG) T2 pulse sequence without temperature compensation
[29]. The acquisition delay was set to 25 seconds, no sample heating was observed under
these conditions as judged by the lack of temperature-dependent perturbations in
chemical shifts. No alterations in peaks shapes due to J-coupling [30] was noticed either.
The bigtau parameter, which is the time between the initial pulse and data acquisition,
was non-uniformly distributed with larger bias to the smaller time values to improve
exponential fit. The bigtau sets were not identical between experiments due to the
variability of the relaxation of the probes (see Table 4.1 for bigtau sets).
The integral for the probe peak of interest was taken in each spectrum of the array.
Errors originating from overlapping peaks were minimized by base-line correction, which
involves subtracting a spectrum of the protein alone from the spectrum of the probe with
additional correction factors to account for concentration differences. The intensities for
the peak of interest were also taken and used to compare exponential fitting parameters
(see supporting information). The fit was carried out using the VnmrJ v3.2 T2 analysis
module. The equation used for the fit was:
𝑦 = 𝑚0 ∗ 𝑒

(

−𝑥
)
𝑇2

+ 𝑚1

(1)

m0 is a constant that corrects for the scaling factor of the integral and m 1 is a constant
that corrects for baseline issues. The T2 measurements were done in triplicates on a
Varian 600 MHz spectrometer equipped with a triple resonance cryogenic probe. The
average T2 was calculated for further analysis.
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Table 4.1. Big Tau Sets for Determining Transverse Relaxation Time
Probe
Protein
BigTau Set (s)
Tert-butyl None
0.1,0.2,0.4,0.6,0.8,1.2,2,3,4,6,8,12,20
alcohol
B-LgA
A-ChytA
Tert-butyl BSA
0.1,0.2,0.4,0.8,1.2,2,3.5,6,8
alcohol
Butanol
None
0.2,0.3,0.5,0.7,1.2,2,3.5,5.5,8,12
BSA
B-LgA
A-ChytA
butanol
BSA
0.1,0.2,0.3,0.5,0.7,1.2,2,3,4.5,6
propanol
None
0.2,0.4,0.6,0.8,1.2,3,6,9,12,20
B-LgA
A-ChytA
propanol
BSA
0.1,0.2,0.3,0.5,0.7,1.2,2,3,4.5,6
phenol
None
0.2,0.5,0.8,1.2,2,4,6,12,24
B-LgA
A-ChytA
phenol
BSA
0.05,0.1,0.2,0.3,0.5,0.7,1.2,2,5
Leu
None
0.1,0.2,0.4,0.8,1.2,2,4,8,16
B-LgA
A-ChytA
Leu
BSA
0.05,0.1,0.2,0.3,0.5,0.7,1.2,2,5
Val
None
0.1,0.2,0.4,0.8,1.2,2,4,8,16
BSA
B-LgA
A-ChytA
Phe
None
0.1,0.2,0.4,0.8,1.2,2,4,8,16
B-LgA
A-ChytA
Phe
BSA
0.05,0.1,0.2,0.3,0.5,0.7,1.2,2,5
Trp
None
0.1,0.2,0.4,0.8,1.2,2,4,8,16
B-LgA
A-ChytA
Trp
BSA
0.05,0.1,0.2,0.3,0.5,0.7,1.2,2,5
Tyr
None
0.1,0.2,0.4,0.8,1.2,2,4,8,16
B-LgA
A-ChytA
Tyr
BSA
0.05,0.1,0.2,0.3,0.5,0.7,1.2,2,5
The minimum number of points used was 9 and experiments performed at different
concentrations (if applicable) all used the same bigtau set. The above table indicates the
combination of protein and probe and their respective bigtau set.
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Measuring the Diffusion Coefficient by DOSY
Preparation of the sample was identical to methods mentioned previously. The
sample was subjected to a pulse sequence of diffusion correlation spectroscopy (DOSY)
called DgcsteSL (DOSY Gradient Stimulated Echo with Spin Lock). For the experimental
parameters, the diffusion delay (del) is 60 ms, total diffusion-encoding pulse width (gt1)
is 2 ms, gradient stabilization delay (gstab) is 0.2 ms, relaxation delay is 10 s, and number
of increments was 15 (values of the gradient level are randomly selected between 1300
and 32500 by the software). The integral area of the signal of interest was used to
calculate the diffusion coefficient through the VnmrJ v3.2 DOSY module.

4.3 – Results and Discussion
4.3.1 – Experimental Considerations
Though NMR is a useful technique for analyzing both small ligands and proteins,
utilizing NMR as a quantitative tool requires extra care. Proper calibration should be and
needs to be done (ex - 90o pulse width) on each individual sample due to sample
variability. The next consideration is the presence of H2O as the experiments are
performed in an aqueous environment. Ideally, the percentage of D2O should be close to
100%, but would be difficult to achieve as it would require the use of deuterated buffering
agents as well as proteins as the amide proton is labile. The buffer itself is made by using
D2O as the solvent, which is how we estimated that the amount of D2O is approximately
90%.
The reason as to why H2O is important to consider is because its concentration far
exceeds the concentration of the probe/proteins in solution. Given that the experiment is
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a simple 1H-CPMG T2, we would observe a signal for water. It would be the dominant
peak by a far margin and would make it unsuitable to observe probe peaks close to 4.7
ppm due to spectral overlap. The suppression of the water signal needs to be done to
obtain a proper baseline, which is achieved by a presaturation pulse prior to the excitation
of the protons. The power of the presaturation pulse has to be as minimal as possible so
that it would not affect the peak of interest.
The confidence in the T2 values obtained can be improved by the use of a
reference compound, which would indicate if the parameters of the experiment were
adequately calibrated as the reference T2 and chemical shift should be the same between
runs. The reference compound can be added into the solution itself (internal reference)
or in a secondary compartment separate from the solution (external reference). Though
an internal reference would be straightforward as it simply requires the addition of equal
volumes of reference compounds into every sample, a problem arises when the reference
compound is not inert. That is, the reference compound is able to interact with the solution
components like the protein. This is observed in our initial tests in which we tested the
binding of tert-butyl alcohol and BSA at two different ratios (Table 4.2). As expected, the
line width of tert-butyl was broadened, which is indicative of binding. However, we see
that our internal reference, 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS), also
showed line broadening. This makes it difficult to properly assess the extent of binding of
tert-butyl alcohol if there are multiple ligands that may or may not bind to the same
interface. Though it is possible to utilize internal references, it requires prescreens to
determine if the compound is truly inert, which can become cumbersome if you are
screening against a large number of proteins.
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Table 4.2. Line Width Variability with an Internal Reference
Line width of
Tert-butyl alcohol (Hz)

Line width of DSS (Hz)

No protein

2.96

2.99

1:100 BSA:tert-butyl

3.64

5.54

1:50 BSA:tert-butyl

4.41

6.43

The line width of tert-butyl alcohol peak (at 1.23 ppm) and DSS (at 0.0 ppm) were
calculated at half height in the presence and absence of BSA. The concentration of DSS
and BSA were held constant at 2 mM and 29 µM, respectively. The concentration of tertbutyl alcohol was 3 mM for the no protein and 1:100 sample while being reduced to 1.5
mM for the 1:50 sample.

The alternative solution is to use an external reference. The benefits are easily
visible as the external reference has no capability of interacting with the protein and can
be removed and reused for a different sample, which means that the external reference
is identical between runs/samples. The downside is that the sample contains two different
compartments of two closely matched, but not identical solution composition. As such, it
becomes troublesome to create a proper homogenized magnetic field, leading to
potentially distorted line shapes. This makes the process for collecting the data much
more tedious especially if the external reference is improperly aligned in the center. As a
result, the T2 experiments performed here were done in the absence of a reference
compound. However, the use of an external references have been used for quantitative
purposes as reported in the literature [29-32] and has given reasonable results for DOSY
using a Wilmad coaxial insert.
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Lastly, the goal of this study is to investigate the extent of hydrophobic interactions
of small probes with a protein standard. Unfortunately, the experiments have to be done
in aqueous solutions so that the proteins are properly folded and behaving normally. This
means that the use of entirely hydrophobic compounds, such as benzene or butane, is
not feasible due to their low solubility. Thus, it is necessary that our compounds contain
a hydroxyl group for increased solubility (ex – phenol and butanol). As a result, there is a
caveat that the interaction may not be completely hydrophobic.

4.3.2 – Line width versus Transverse Relaxation Time
In order to determine if a small molecular weight probe interacts with a larger
macromolecule target, such as protein or DNA, it is possible to track changes in the probe
relaxation rate through nuclear magnetic resonance (NMR) spectroscopy [33-35]. Large
molecules will have longer correlation times and relax faster in solution, which is important
because binding of the probe to the protein will result in a faster relaxation rate for the
probe [36]. The parameter, which correlates with relaxation rates of molecules and could
be directly derived from any NMR spectrum, is the line-width of the molecules’
corresponding peaks. The true line-width and T2, the transverse relaxation time, are
related by the equation:
1

𝜗1⁄2 = 𝜋𝑇

2

(2)

thus, indicating the plausibility to use either line-width or T2 to monitor the binding of the
probe to the protein. However, in our initial attempt to develop a general method for
measuring weak non-specific probe interactions with hydrophobic surface areas of
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proteins, we have found out that line-width was not an optimal parameter to use. In
practice, the measured line-width is affected by artifacts as shown by the equation:
𝜗𝑎𝑐𝑡𝑢𝑎𝑙 = 𝜗1⁄2 + 𝜗𝑛𝑜𝑛−ℎ𝑜𝑚

(3)

The large errors in line-width measurements are predominantly associated with magnetic
field non-homogeneity and are caused by difficulties achieving exactly the same shims
between samples, which would overshadow the small difference in line-width that would
arise from weak binding. From this perspective, measuring T2 is a better choice as it
minimizes the problem of magnetic field inhomogeneity. The T2 relaxation was
determined by fitting the data points (in form of peak integrals or intensities) in time array
to equation 1 as shown by the example in Figure 4.1.

4.3.3 – Intensity versus Integral
There are two possible methods that can be used to observe the exponential decay
of the peak of interest. This can be either done by monitoring the intensity of the peak at
a certain chemical shift or by taking the integral of a defined region. There are several
benefits of using integral over intensity. First, integrals are less error prone because
random noise in the defined region will be predominantly canceled out. Second, intensity
is more sensitive to a number of factors not particularly related to binding, such as the
line shape and possible chemical shift changes due to temperature instability.30 Though
integrals are more favorable to use over intensity, there are problems associated with
overlapping peaks, especially in the case of broad protein peaks underneath the sharp
probe peak. Integration over that region would combine the areas of both the signal of
interest and those unwanted peaks, resulting in difficulties fitting the data and inaccurate
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T2 measurements. It is necessary to do protein peaks subtraction before fitting for such
cases where significant overlap is visible and it is not possible to choose probe peaks
from other chemical shifts regions. An example of using integration to determine the T2
relaxation time is shown in Figure 4.1, where the peak area is taken at different time
intervals for the phenol triplet peak at 7.34 ppm.

Figure 4.1. Representation of an Exponential Decay and Fit. A sample exponential
decay (of 3 mM phenol) obtained from the CMPG-T2 experiment. The exponential is fit
with the equation 1. The variables of the fit were m0 = 99.2, m1=0.88, and t2=5.147 s.
The inset depicts the peak of interest (triplet at 7.34ppm) at consequent time points in the
array.
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4.3.4 – Analysis of T2 Binding
As the binding of the small probe is expected to be weak and non-specific (with a
dissociation constant in the high mM range), it is reasonable to assume that the
equilibrium between the free and bound state is in fast exchange (Lepre et al., 2004).
Because of this, the analysis of the extent of binding becomes less complex, where the
T2 observed is simply proportional to the populations of the free and bound states:
1
𝑇2𝑜𝑏𝑠

1

= 𝑓𝑏 𝑇 + (1 − 𝑓𝑏 ) 𝑇
2𝑏

1
2𝑓𝑟𝑒𝑒

[𝑆𝑃]

where 𝑓𝑏 = [𝑆]

𝑡𝑜𝑡𝑎𝑙

(4)

where T2obs is the T2 observed (probe in the presence of protein), T2b is the T2 of the
bound state, which is assumed to be the T2 of the protein, T 2free is the T2 of the free
probe, and fb is the fraction of probe bound. The 1H transverse relaxation times of proteins
were experimentally determined to be 0.030 s, 0.020 s, and 0.003 s for B-LgA, A-ChytA,
and BSA, respectively. We can then solve for the amount of fraction bound, where the
equation becomes:
𝑇

𝑓𝑏 = 𝑇2𝑏

(𝑇2𝑓 −𝑇2𝑜𝑏𝑠 )

2𝑜𝑏𝑠 (𝑇2𝑓 −𝑇2𝑏 )

(5)

When we consider nonspecific interactions, the probe is likely to bind to multiple sites on
the protein. To simplify matters, we assume that there are n equivalent binding sites,
which gives use the binding model:
[𝑆𝑃]
[𝑃𝑜 ]

[𝑆]

= 𝑛 ([𝑆+𝐾 ])
𝑑

(6)

We can rearrange equation 6 to include the fraction bound to get:

𝑓𝑏 = 𝛼 − √(𝛼 2 − 𝛽 )
where
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𝛼=

[𝑆]𝑜 +𝑛[𝑃]𝑜 +𝐾𝑑
2[𝑆]𝑜

(8)

and
𝛽=

𝑛[𝑃]𝑜
[𝑆]𝑜

(9)

From this binding model, we can see that the T2 values obtained in the experiment can
be used to determine the Kd, and n. However, this is highly dependent on how it is fit [37]
and could lead to data over-interpretation due to multiple unknown variables. Thus,
quantification of the binding becomes difficult and we opted to provide a semi-quantitative
approach by comparing the fraction bounds of the probes instead.

4.3.5 – Concentration Dependent Change in Fraction Bound
In order to investigate if fraction bound was a suitable measure for semiquantitative analysis, we conducted a series of T2 experiments at different ratios of probe
to protein as exemplified in Figure 4.2. The two model probes (phenol and tert-butyl
alcohol) were tested against BSA, A-ChytA, and B-LgA, where the probe concentration
was held constant and the protein concentration was increased. As shown, the increase
in protein concentration causes a linear increase in the proportion of the fraction bound,
at least at concentrations where the probe is still in large excess.
If we were to provide a linear fit, the steepness could be considered as a semiquantitative measurement of protein hydrophobicity, where steeper slops are correlated
to a larger degree of bound probe compared to a shallow slope. Thus, we can deduce
that BSA is the most hydrophobic whereas B-LgA is the least based on phenol. Tert-butyl
alcohol had less affinity for BSA than phenol and no significant association with A-ChytA
and B-LgA.
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Figure 4.2. Increasing Protein Concentration Results in a Larger Population of
Fraction Bound. Plot showing the fraction bound of probe vs the concentration of protein.
The probe:protein mixtures are labeled and a linear fit of each data set is shown. Two
sets of data are shown for phenol:A-ChytA to better represent the variability of T2s
obtained, which is due to protein degradation/activation at different time points of protein
preparation.

Also, Figure 4.2 illustrates that, the T2 measurements of phenol was fairly
inconsistent in the presence of A-ChytA, which was quite surprising. Upon further
investigation of A-ChytA’s behavior in solution, we found that it is most likely due to the
propensity of A-ChytA to degrade/oligomerize over time, which could be potentially
related to the autocatalysis from trace impurities of chymotrypsin [38]. Dr. Zecca also
performed time based analysis of A-ChytA and determined that A-ChytA does degrade
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over time and begins to degrade within a day. Thus, it is imperative that proteins are
prepared fresh to minimize artifacts arising from degradation products. Alternatively, this
could serve as a basis for determining if there are any changes in sample integrity.
Lastly, investigation of probe-protein interactions at a multitude of ratios can be
time consuming. To streamline the process, we opted to investigate the differences of
fraction bound at a particular ratio. As seen in Figure 4.2, there are noticeable differences
in the individual fraction bounds at a particular ratio, but this approach requires that there
is a sufficient amount of probe bound to have more confidence in the measured
differences in the T2 and fraction bound values. For this, we chose the 1:50 ratio and
prepared fresh samples for all subsequent experiments.

4.3.6 – Comparison of Aliphatic and Aromatic Probes
As previously shown by the concentration dependent changes in the fraction
bound, the extent of phenol binding to the protein standards was much higher in
comparison to tert-butyl alcohol, suggesting that these interactions are not equivalent.
This is further extended to include additional probes as shown in Table 4.3, which
encompasses more aliphatic probes. Though we were not able to find another suitable
aromatic probe (preliminary tests with benzyl alcohol showed an irregular chemical shift
pattern with multiple unique proton peaks overlapping, which is not ideal for peak analysis
through integration or intensity), the results showed similar patterns with tert-butyl alcohol,
where 1-propanol and 1-butanol interacted with BSA. The percent decrease in the T2 was
fairly higher for 1-propanol (60%) and 1-butanol (73%) in comparison to tert-butyl (21%).
Likewise, there was no perceptible binding of the aliphatic probes to either A-ChytA or B-
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Table 4.3. Percent Reduction in T2 Relaxation Times of the Probes upon Binding
to the Proteins.
Protein
BSA

A-ChytA

B-LgA

Probe
Tert-butyl alcohol
1-butanol
1-propanol
Phenol

21
NB
NB
73
NB
NB
60
NB
NB
97
11
18
Capped Amino Acids
Leucine
58
9
NB
Valine
17
NB
NB
Phenylalanine
84
NB
8
Tryptophan
94
21
19
Tyrosine
79
6
NB
The values shown above are the percent reduction in T2 when compared to the T2 of the
free probe using the average T2 value obtained, where percent change = 100 ∗ (𝑇2𝑓 −
𝑇2𝑜𝑏𝑠 )/𝑇2𝑓 . Percent changes of less than 5% were within experimental error and are
denoted with NB (no binding). The ratio for protein:probe is 1:50, where the protein
concentration is 0.03 mM and the probe is 1.5 mM. T2 of the free probes and integration
regions are: tert-butyl alcohol = 2.32s (1.28-1.18ppm), 1-butanol = 2.69 s (0.86-0.6 ppm),
1-propanol = 3.32 s (0.86-0.6 ppm), phenol = 5.16 s (7.4-7.26 ppm), leucine = 0.67 s
(0.84-0.7 ppm), valine = 0.83 s (0.95-0.6 ppm), phenylalanine = 2.04 s (7.28-7.08 ppm),
tryptophan = 2.20 s (7.56-7.45 ppm), tyrosine = 1.46 s (7.14-6.86 ppm).

LgA. On the contrary, phenol does interact with all three proteins and had a significant
drop in T2 in the presence of BSA (97%), leading to a hydrophobicity order from most to
least:
BSA > B-LgA > A ChytA
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4.3.7 – Usage of Capped Amino Acids as Probes
As the goal of this study is to determine the surface hydrophobicity and attempt to
correlate that to how proteins/antibodies behave in solution, we expanded the library of
probes to include amino acids. The amino acids normally have charged ends due to the
amino and carboxylic acid functional groups, so it was necessary to utilized capped amino
acids, where the amino group is acetylated and the carboxylate is methylated. With the
charges neutralized, we focused on the interaction of the side chains. Table 4.3 shows a
similar pattern to our small molecular probes, where the aromatic amino acids have a
large decrease in their T2 values in the presence of BSA in comparison to the aliphatic
amino acids. The aliphatic amino acids exhibited no binding to A-ChytA or B-LgA. The
9% decrease for Leu can be attributed to its low T2 (0.67 s alone and 0.61 s in the
presence of A-ChytA).
On the other hand, the aromatic amino acids were expected to interact with both
A-ChytA and B-LgA due to similarities with phenol. Trp bound to both proteins, but both
Tyr and Phe showed weak or no binding. Due to the inconsistencies in the T2, we
questioned the reliability of these capped amino acids as probes. Since the side chains
are most likely not the factor, we hypothesized that the capped C- and N-termini were
responsible, which would be due to increased bulkiness and more steric hindrance.
Furthermore, we found that different conformations of capped amino acids exists
in solution. In general, the different conformations of a compound are readily
interconverted in solution, so the corresponding peaks in the 1H NMR spectrum represent
an average of the conformations. However, we found that capped amino acids have
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different conformations in slow exchange, leading to at least two distinct conformations
of non-equal populations. This is demonstrated in Figure 4.3, which depicts the aromatic
region of the 1H spectrum for Trp. Since Trp only has five unique aromatic protons, we
can conclude that there are multiple conformations of Trp as manifested by the more
complex pattern of peaks. The integrations of the peaks (as described in the figure
legend) suggests that it is indeed five protons.
This is further complicated because each individual conformation behaves
differently in solution as observed by the differential binding patterns (Figure 4.3). If we
were to focus on the left most hydrogen, we see that the left doublet at 7.54 ppm in the
presence of BSA and partially disappears with B-LgA, but remains with A-ChytA.
Conversely, the right doublet at 7.48 ppm disappears in the presence of A-ChytA, but not
BSA or B-LgA. This is highly undesirable as the exponential fit is complicated due to the
differing binding capacities of individual conformations, which then necessitates the use
of a multiple exponential fit rather than a single exponential. For example, taking the
integral over the range from 7.56 ppm to 7.45 ppm to examine the T2 of one hydrogen
would no longer be appropriate for analysis by equation 1 due to the presence of multiple
unique protons.
Thus, the T2 values defined from these experiments becomes questionable.
Though this interaction-based conformational heterogeneity is interesting on its own
terms, it serves little purpose to the goal at hand. Based on these findings, we concluded
that Trp is not an appropriate probe to use. Furthermore, different conformations were
also observed for Leu and Tyr, but not Phe and Val. Though Phe and val do not explicitly
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Figure 4.3. Conformations of Trp and their Behavior in the Presence of Proteins.
Capped-Trp spectra are shown zoomed on the aromatic region. The concentrations of
Trp (shown for Trp alone in A) are 3 mM and the ratio of Trp to proteins, (shown for BSA
in (B), for A-ChytA in (C), and for B-LgA in (D)), is 1:100. Integration areas are: 7.56-7.45
ppm = 0.99, 7.4-7.3 ppm = 1.02, 7.15-7.06 ppm = 2.0, 7.05-6.98 ppm = 0.99. This
correlates to the five aromatic protons of Trp.
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show different conformations within the NMR spectra, it is better to err on the side of
caution and avoid their use.

4.3.8 – Applicability of DOSY
Since we had found that T2 is a reasonable parameter for determination of the
surface hydrophobicity of a protein, we investigated the possibility of using an alternative
parameter to quantify the interaction between the probe and protein. The purpose of this
was to replicate our findings in a different experiment to corroborate the surface
hydrophobicity. For this, we opted to look at the diffusion coefficient, which would be
determined through DOSY. The analysis of the diffusion coefficient is highly similar to T2,
where the probe/protein complex are in fast exchange, leading to the dependence of the
observed diffusion coefficient on the populations of the free and bound states:
𝐷𝑜𝑏𝑠 = 𝑓𝑏 𝐷𝑏 + (1 − 𝑓𝑏 )𝐷𝑓𝑟𝑒𝑒

(10)

where Dobs is the observed diffusion coefficient of the probe in the presence of protein, Db
is the diffusion coefficient of the bound state, f b is the fraction of probe bound, and Dfree is
the diffusion coefficient of the free probe.
Though we had hoped that the diffusion coefficient would provide similar results to
our T2 experiments, the conclusion was that DOSY was not an adequate approach for
investigating weak interactions. As presented in Table 4.4, the change on the diffusion
coefficient of phenol in the presence and absence of proteins. The most significant
change is anticipated to be with BSA, which showed a 97% decrease in T2. Here, we see
that the diffusion coefficient dropped from 3.74x10-10 m2/s to 3.59x10-10 m2/s, which
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Table 4.4. Determination of Diffusion Coefficients.
Sample

Diffusion coefficient (10e-10 m2/s)

Phenol Only

3.7400

Phenol + BSA

3.5940

Tert-butyl alcohol Only

3.1794

Tert-butyl alcohol + BSA

3.0922

DSS

2.3821±0.022

The diffusion coefficient of the samples were calculated by peak integration (phenol =
7.4-7.26 ppm, tert-butyl = 1.28-1.18 ppm, DSS = 0.05--0.05 ppm). The concentrations
were 3 mM for BSA and 1.5 mM for the probe. The concentration of DSS (in an external
compartment) was 5 mM. The external reference was reused for multiple runs for
calibration and test runs, which is how the diffusion coefficient and standard deviation of
DSS was calculated (n = 16). No error is given for the other runs as they were only run
once.

amounts to a 4% decrease. This drop is very modest and falls close to experimental error.
Though the probe/protein experiments were only run once as a test, we also analyzed
the diffusion coefficient of DSS a multitude of times (n= 16), which was determined from
be 2.382 ± 0.022 x10-10 m2/s, where the error itself amounts to ~1%. Though the
difference is above the error, the difference is still minimal, which means that it further
experiments would require a lower probe:protein ratio like 1:20 rather than 1:50. However,
lower ratios are more problematic due to either the lower signal to noise of the probe
(lower probe concentration) or more protein spectral overlap (higher protein
concentration).
To understand what the problem could have been, we theoretically determined the
diffusion coefficient of the protein (Db) based on the Stokes-Einstein equation [39]:
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𝐷=

𝑘𝑇
6𝜋𝜂𝑟𝐻

(11)

where the diffusion coefficient, D, depends on the Boltzmann constant (k), temperature
(T), viscosity (η), and the hydrodynamic radius (rH). The hydrodynamic radius of a protein
is variable, but we can simply assume that it adopts a spherical shape for this calculation,
which means that the minimum radius [40], assuming the specific volume of a protein is
0.73 cm3/g, is:
3

𝑅𝑚𝑖𝑛 = 0.066 √𝑀

(12)

where Rmin is related to the cubic root of the molecular weight (M). Once we plug in the
values, we see that the estimated Db for BSA is 0.915 x 10-10 m2/s, which is markedly
close to the Dfree of phenol. This is most likely the reason why the effect of binding is
minimal for DOSY as the difference between the Dfree and Db is much smaller than T2free
and T2b. Thus, we were unable to use DOSY to validate our T2 experiments.

4.3.9 – Correlation with HIC and Fluorescence
Though DOSY was not an effective method for this project, investigation of the
surface hydrophobicity by Dr. Zecca through HIC and Fluorescence showed promising
results. The hydrophobicity order, from most to least, that was established by NMR was
BSA > B-LgA > A-ChytA with phenol as the probe.
For fluorescence, an extrinsic fluorescence probe ANS was used, where its
quantum yield and wavelength of maximum fluorescence depends on if it is present in an
aqueous or hydrophobic environment. Through this, it was determined that the surface
hydrophobicity (measured by the initial slope S0 as shown in Table 4.5) order was BSA >
B-LgA > A-ChytA, which coincides well with our NMR data. This is further validated
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Table 4.5. Initial slopes (S0) of ANS bound to BSA, B-LgA and A-ChytA.
Protein

Surface Hydrophobicity (S0)

BSA

1355.2

B-LgA

15.4

A-ChytA

2.8

The initial slope of the relative fluorescence intensity (RFI) at 470 nm is shown above for
each individual protein with ANS as the extrinsic dye, where the initial slope is
representative of the surface hydrophobicity.

Figure 4.4. HIC Elution Profiles. The HIC elution profiles of BSA, A-ChytA, B-LgA, and
Mixture on (A) Phenyl HP or (B) Butyl HP column are shown above, where the proteins
were detected by monitoring the absorbance and 280 nm. The gradient was a 30 minute
linear gradient of 1.0 M to 0.0 M ammonium sulfate in 20 mM sodium phosphate at a 0.5
mL/min flow rate. The column was continually washed with 20 mM sodium phosphate
after 30 minutes to allow all the protein to elute and the baseline to return to normal.
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through HIC, where the protein is subjected to an immobilized hydrophobic phase. The
more hydrophobic proteins would remain bound to the column and would be difficult to
elute, so that the elution profile would give an indication as to the relative hydrophobicities
of the proteins. In Figure 4.4, the retention times showed that the hydrophobicity orders
were similar, where A-ChytA was the least hydrophobic and BSA was the most. The order
was the same when we utilized an immobilized aliphatic (butyl) or aromatic (phenyl)
phase.
The elution profiles do show that there are multiple peaks, indicating heterogeneity
in the sample arising from fragments/aggregates or different conformations. This behavior
could potentially be attributed to the ammonium sulfate concentration and/or the strength
of the hydrophobic stationary column [41]. In particularly, BSA has been reported to
change conformations upon binding to a butyl HP column and unfolded proteins are
difficult to elute off, resulting in broader peaks [42]. Therefore, it is difficult to assess the
overall extent of aliphatic and aromatic interactions due to these caveats. However, we
do observe that there are distinct differences in the overall elution pattern. B-LgA has a
relatively sharper peak for the phenyl column, which could be due to stronger π-π
interactions. On the other hand, A-ChytA has multiple peaks for both column, but
possesses an additional peak for the phenyl column [43], implicating that there is a
difference when comparing aliphatic and aromatic interactions, which coincides with what
we observed with NMR.
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4.4 – Conclusion
We experimentally determined the order of hydrophobicity to be BSA > B-LgA >
A-ChytA, from most to least by NMR, HIC, and Fluorescence. This helps to prove that
solution NMR is a fast and robust technique that is able to investigate the interaction
between small molecular probes and proteins, where aliphatic and aromatic probes were
determined to have differences in the non-specific binding capabilities. The use of capped
amino acids revealed that the amino acids had multiple conformations, which is most
likely due to the bulkier capped ends. Therefore, it is advised to not use capped amino
acids despite its potential for mimicking protein-protein interactions.
Though we see hydrophobicity order matches between the three techniques
utilized, there still remains questions that need to be answered. For instance, further
studies are needed to better characterize phenol as an optimal binding probe (or possibly
find another small aromatic probe), to determine a suitable method for quantification of
surface hydrophobicity by NMR, to understand how and when aliphatic probes bind, how
sample integrity relates to the observed differences T2, and to characterize monoclonal
antibodies, whom are industrially relevant. Nonetheless, we feel that NMR is a versatile
technique that is suitable for measuring surface hydrophobicity in which we hope can be
used as a predictive measure for protein behavior in solution.
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The work presented in this dissertation has covered a wide range of goals and
biological systems. However, the core that ties them all together is that investigation
protein-protein and protein-ligand interactions are crucial for understanding structural
features/changes as well as their functional role in vivo.
Chapter 2 explores the interaction between CD47 and PLIC-2 as a novel protein
complex that could be related to how CD47 ultimately modulates the cytoskeleton.
However, the in vitro results using the isolated domains of PLIC-2 and the cytoplasmic
tail of CD47 isoform proved to be fruitless, where no detectable interaction was
observed through ITC or NMR. The addition of a membrane mimetic (nanodiscs) did not
provide positive results. On the other hand, PLIC-2, also known as ubiquilin-2, was
shown to be able to self-associate (UBA/UBL complex) as well as bind to ubiquitin
through its UBA domain, which is in line with the literature that have shown ubiquilin’s
role in ubiquitin mediated protein degradation. Though it is unlikely that CD47 and PLIC2 associate, it may be reasonable to test other constructs (full length PLIC-2, full length
CD47, CD47/integrin complexes). The additional residues could be a requirement for
interacting, especially considering that our in vitro experiments may not be an ideal
representation of in vivo conditions.
Chapter 3 investigates the activation mechanism of BTN3A1, who responds to
intracellular pAg in order to activate Vγ9Vδ2 T cells. Association of the B30.2 and
HMBPP causes minimal changes in the B30.2 domain based on the crystal structure,
but there was an apparent change with the JM region by NMR. Further investigation of
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the JM region specifically showed that the JM is able to interact with negatively charged
diphosphate molecules in which two threonines were identified to be important. The
binding itself was weak, but was corroborated with SAXS, ITC, and cellular assays.
Therefore, this conformational change upon ligand association is particularly interesting
to understand how pAg can activate BTN3A1. The data provided here does not provide
a clear picture of the molecular details and binding interfaces as well as if this
conformational change directly influences the conformation of its extracellular domain
and/or binding affinity towards other protein partners. These questions will have to be
addressed in future endeavors.
Chapter 4 involves the use of small hydrophobic probes as a means for
evaluating the surface hydrophobicity of a protein through NMR. The work here
explores the limitations and benefits of T2 as a quantitative method. The results show
that the probes are able to interact with the protein, leading to a depression in their
observed T2 value. The hydrophobicity order determined by phenol was consistent with
current standards (HIC and fluorescence). To improve upon what has been done, it
would be beneficial to expand the protein library and to include monoclonal antibodies,
identifying how and when aliphatic/aromatic probes would bind, and correlation to
solution properties, such as aggregation.
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Appendix Chapter A1 – A Structural Model of the
Skelemin and Integrin αIIbβ3 Complex

Adapted from: Gorbatyuk, V., Nguyen, K., Podolnikova, N., Deshmukh, L., Lin, X.,
Ugarova, T., and Vinogradova, O. Skelemin Association with aIIbβ3 Integrin: A Structural
Model, Biochem., 2014, 53: 6766-6775.

A1 – Introduction
It has been known that cell adhesion is primarily mediated by integrins 1 by which
it connects the extracellular matrix to the cytoskeleton. It begins with the clustering of
proteins to form a small network called motility induced focal complexes (FXs), which
could ultimately be replaced by focal adhesions (FAs) in fully spread cells 2. However,
understanding the formation and components of FXs and FAs is crucial to understanding
how the cells regulate cellular adhesion. The work presented in this chapter focuses on
the role of skelemin, which is a protein found to be localized with FXs, but not FAs 3.
Skelemin, also known as myomesin 1.1, is a 185 kDa muscle M-line cytoskeletal
protein that is predominantly expressed in embryonic heart4, playing a crucial role in the
early stages of cell spreading5. Skelemin is comprised of a unique N-terminal myosin
binding domain, 5 fibronectin (FN) type III like domains, 6 immunoglobulin like C2
domains (IgC2), and a C-terminal immunoglobulin domain responsible for dimerization6
as shown in Figure A1. The importance of skelemin in understanding FXs is that it has
been shown that its IgC2 domains 4 and 5, hereafter referred to as Sk45, directly
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Figure A1. Simplistic Diagram of Skelemin’s Domains. It consists of a unique Nterminal myosin binding domain (MBD), seven IgC2, and five FN Type III-like domains.
The IgC2 domains are numbered (shown within the ellipse) to more easily visualize the
location of IgC2 domains 4 and 5.

associated with the cytoplasmic tail of integrin β3 and integrin αIIb7,8. Considering that
integrin exists as a heterodimer of α and β subunits, this lends itself to the proposition that
Sk45 is able to simultaneously bind to both integrin subunits, in which it may then
modulate the cytoskeleton through contractile force and/or the recruitment of other
cytoskeletal proteins to the integrin cluster9. Given that there is evidence that skelemin is
crucial for cell spreading and is able to associate with both integrin αIIb and β3, the goal of
the chapter presented here aims to deduce the overall structure of the skelemin and
integrin complex.

A2 – Materials and Methods
Mutagenesis, Expression, and Purification
For these experiments, mouse skelemin was cloned into E. coli. Single site
mutagenesis of Sk45 of K1424 to C was performed using the QuikChange kit (Agilent
Technologies). The mutant plasmid was transformed into Rosetta (DE3) competent cells
(EMD Millipore). Protein expression was carried out using LB or M9 minimal media with
15NH Cl
4

as the sole nitrogen source at 37 oC. Cultures were grown to an OD600 of ~0.6
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and induced with 1mM of IPTG. After 4 hours, the cells were collected by centrifugation.
For purification, cells were resuspended in buffer (20 mM Tris, pH 8, 300 mM NaCl, 10
mM imidazole, 1 mM DTT, 1mM PMSF, 1 tablet of complete protease inhibitor cocktail
(Roche Applied Sciences) and lysed by passage through a French press (Thermo
Electron). The supernatant was incubated with Ni-NTA agarose resin (Qiagen) and the
protein was eluted with a buffer containing 20 mM Tris, pH 7.5, 300 mM NaCl, and 500
mM imidazole. For cleavage of the His-tag, thrombin was added directly to the Ni-NTA
column, where cleavage was done at 37 oC for 4 hours with periodic mixing (50 mM Tris,
150 mM NaCl, 1 mM EDTA, pH 7.5). Thrombin was subsequently inhibited by the addition
of equivalent amounts of PMSF. The eluate was further purified by size exclusion
chromatography (16/60 Superdex 75 column, GE healthcare) in 50 mM NaCl, 20 mM
KPO4, pH 6.8.

Paramagnetic Relaxation Experiments
NMR experiments were performed on uniformly

15N-labeled

samples prepared in

buffer containing 20 mM KPO4, pH 6.8, and 7% D2O. Spectra were recorded at 25 °C on
Varian INOVA 600 MHz spectrometer equipped with cold probe. Paramagnetic relaxation
enhancement (PRE) experiments were performed with Sk45 K1424C construct, where
the solvent exposed K1424 was mutated to cysteine. The 1H-15N HSQC spectra were
collected on the samples with and without 3-maleimido-PROXYL (m-PROXYL) spin label.
The effect of the spin label on the signal intensities was estimated from the normalized
intensity differences in the spectra with and without the spin label.
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Isothermal Titration Calorimetry
Isothermal Titration Calorimetry was performed on a low volume Nano ITC (TA
Instruments). Peptides corresponding to integrin cytoplasmic tails were solubilized in the
buffer 50mM NaCl, 20mM KPO4, and pH 6.8. All ITC experiments were performed at
25oC, 300 rpm mixing, 300 seconds time intervals between injections, and 3µl injection
volumes. The concentrations used are as follows: 2.5 mM C-terminal β3 and 0.175 mM
Sk4, 1.3 mM N-terminal β3 and 0.177 mM Sk45, and 1.9 mM αIIb and 0.177 mM Sk45.
The analysis of the data was done in NanoAnalyze Software (TA Instruments) suite using
“Independent” model.

A3 – Results and Discussion
Table A1. Thermodynamic Analysis of the Association of Skelemin and Integrin
by ITC
Titrant
Protein
Kd (µM)
∆G (kJ/mol)
∆H (kJ/mol)
-T∆S (kJ/mol)
Stoichiometry, n

C-terminal β3
Sk4
16.7
-27.3
-0.6
-26.6
1.00

N-terminal β3
Sk45
37.2
-25.3
-1.7
-23.6
1.30

αIIb
Sk45
14.2
-27.7
-1.6
-26.1
1.26

Skelemin IgC domains 4 and 5 have been shown to interact with β3 cytoplasmic
tail previously10. To address the mechanism of this interaction and to define the
thermodynamic forces driving the process, we have employed ITC. We have used Sk4
and Sk45 constructs titrated with either full length αIIb cytoplasmic tail or short synthetic
peptides corresponding to β3 N-or C-termini. The results, summarized in Table A1,
revealed very weak interactions, which were in the tens µM range, that were
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predominantly driven by entropy. For all cases, the stoichiometry of interactions was
found to be one. The data also depicts that the C-terminal region of β3 interacts with the
fourth IgC domain (Sk4) whereas the N-terminal region of β3 likely interacts with the fifth
IgC domain (Sk5). Sk5 was not able to be tested independently due to stability problems
in the absence of the fourth IgC domain.
It is also important to note that the affinity of the cytoplasmic tails of α IIb and β3 is
around 5 µM, which is stronger than their affinity towards skelemin. This supports the
notion that skelemin serves as a modulator and not an activator of integrin, where
skelemin is able to associate after integrin is activated and its cytoplasmic tails are
separated. The hypothesis that skelemin is able to interact with both α IIb and β3 is further
corroborated as αIIb and β3 had unique binding interfaces on Sk5 as determined by
chemical shift perturbation experiments (performed by Dr. Deshmuhk). The residues of
Sk5 identified were 1361, 1363 and 1394 for αIIb and 1368, 1370, 1372, 1374, 1382-1384,
and 1411 for N-terminal β3. With this information, we were able to dock the cytoplasmic
tails of αIIb and β3 onto Sk45 to provide a model system.
However, the structure of Sk45 was not yet solved from the NMR constraints
obtained due to the fact that the Sk4 and Sk5 domains were connected by a flexible linker.
This resulted in inadequate resolution of the orientation between the two domains due to
the lack of long distance restraints, which was then tackled through the use of residual
dipolar coupling (RDC) and paramagnetic relaxation enhancement (PRE) experiments.
RDC data provided additional long distance restraints for the structure calculations, which
were performed by Dr. Gorbatyuk. The potential structures were thinned out by their
agreement with the PRE data (Figure A2), which showed that m-proxyl attached at
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Figure A2. Visualization of PRE Affected Residues. Effects of m-proxyl on peak
intensities of Sk45 were quantified by I ÷ Io, where I and Io is the intensity in the presence
or absence of m-proxyl, respectively. Values closer to 0 represent highly affected
residues. These changes are visualized on the crystal structure of human myomesin
(PDB ID: 3RBS). Peaks that could not be quantified at colored black and the tag location
(K1424C) is colored red. As shown, the residues that are mostly affected lies on Sk5
(circled in red) and are in close proximity to K1424C.

position 1237 of the Sk45 K1424C only had an effect on the residues within the Sk5
domain. This suggests that the two domains are likely to be far apart, where it is unlikely
for the Sk5 domain to fold back to be in proximity of the Sk4 domain. Thus, the end result
is an ensemble of structures (PDB ID: 4V10) of skelemin in a fairly extended state.
From there, the structure of Sk45 was used to dock the cytoplasmic tails of αIIb and β3
through the HADDOCK webserver11, where the composite model is shown in Figure A3.
The electrostatic potential was calculated by using Adaptive Poisson-Boltzmann Solver
(APBS)12 and the pdb2pqr webserver13 using PARSE as the forcefield and PROPKA
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Figure A3. Model of the Integrin/Skelemin Complex. (A) Model of tertiary
integrin/skelemin complex by HADDOCK: Sk45 (tan), αIIb (green), and β3 (purple). The
inset shows hydrogen bonding network. (B) Zoomed view of the binding interface with
Sk5 (colored by electrostatic potential, where the gradient is -10 (red), 0 (white), and 10
(blue)). (C) The tertiary complex is arbitrarily placed with respect to the lipid bilayer. Each
side is shown to better visualize the binding pockets and potential orientation with the lipid
bilayer. The inset depicts positively charged residues (colored in blue) that may interact
with the lipid bilayer.
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to assign protonation states. Based on this model, we see a number of van der-Waals
interactions between αIIb and Sk5’s predominantly hydrophobic binding pocket. The major
interactions are αIIb F992 and F993 side chains with I1392 and the side chain of αIIb W 988
making hydrophobic contacts with F1388, K1389 and, possibly, D1387 of IgC5. Additionally, a
hydrogen bond is formed between K994 amine of αIIb and the backbone oxygen of A1343.
On the other hand, the β3/skelemin interface is mostly based upon a network of
hydrogen bonds between β3 N-terminus and Sk5 as well as the linker between Sk4 and
Sk5. The electrostatic surface potential of the zoomed Sk5 region presented in Figure
A3B helps to visualize mostly hydrophobic cleft on the left interacting with α IIb subunit and
predominantly negatively charged binding site for β3 subunit on the right. N-terminal K716
and K725 of β3 forms hydrogen bonds with the side chain of E1384 and the backbone oxygen
of D1415, respectively. There are hydrophobic interactions between β 3 H722 and the side
chain carbons of Sk45 K1413 and E1368. From the skelemin side, Sk5 K1418 forms an
extensive hydrogen bonding network, which includes β 3 residues D723, through both the
side chain and backbone oxygen, and β3 E726, through the side chain only. Two hydrogen
bonds are found within skelemin linker helix: the side chain nitrogen of K1321 is connected
to β3 N744 while E1328 oxygen interacts with the side chain amine of R736. Though there is
no direct experimental evidence to pinpoint the residues involved for Sk4, the model
demonstrates no major interactions between IgC4 and β 3, with only a couple of
hydrophobic contacts found between side chains of IgC4 residues E1293 and N1294 and β3
A750.
In Figure A3C, we also show the positioning of the tertiary complex with respect to
the lipid bilayer. As presented, one potential arrangement is that the skelemin Ig domains
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4 and 5 may be placed parallel to the membrane surface. With this, the αIIb subunit comes
out of the membrane almost perpendicularly with its W 988 side chain making contacts with
lipid head-groups at the membrane-cytoplasm interface. Integrin β3 is arranged at a sharp
acute angle with its K716 side chain making contacts with negatively charged patch on the
surface of Sk5. The top surface of Sk5 contains positively charged residues, which could
associate with the negatively charged lipid membrane.
Lastly, the structure of skelemin’s IgC domains were also solved by Pinotsis and
colleagues14 for the human isoform by crystallography (PDB ID: 3RBS). The structures
coincided well with our NMR structure, where they adopted a well-known IgC2-fold,
containing seven β-strands in two β-sheets forming two β-sandwiches. However, the
major difference between the crystal and NMR structure lies within the linker region
between the IgC2 domains (Figure A4). As shown, the crystal structure found that the
linker region is highly helical, which depicts that the linker is rigid. In our solution structure,
the N-terminal region of the linker adopts a helical fold that rests upon the Sk4 domain,
which coincides with evidence that the Ig domain/helix interface area is structurally
conserved throughout other Ig tandem domains of myomesin-114. Strikingly, the Cterminal region of the linker was found to be flexible in solution, which allows for larger
spatial orientations between the two IgC2 domains. Nonetheless, the difference between
the crystal and solution structure can depict the elasticity of skelemin, where the linker
region can serve as the springs/sensors of mechanical force. This is in line with current
evidence as it has been shown that myomesin has similar elastic properties as titin
through atomic force microscopy14,15.
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Figure A4. Comparison Between the NMR Ensemble and the Crystal Structure. The
overlay of Sk45 NMR ensemble (the 20 lowest energy NMR structures with the two
domains oriented by means of RDC data) with the X-ray structure of human homolog
(PDB ID 3RBS). The NMR ensemble and the X-ray structure (violet) are superimposed
over residues 1227-1327 (domain Sk4) and 1344-1427 (domain Sk5). The linker region
is magnified and is shown in ribbon presentation for X-ray structure to highlight the
difference in rigidity.

A4 – Conclusion
To conclude, we have determined by NMR a three dimensional structure of tandem
IgC2-like domains 4 and 5 of skelemin, where the linker is less ordered / more dynamic
than suggested by earlier X-ray studies of the human homolog myomesin-1. We show
that interaction between skelemin and integrin cytoplasmic domain is weak and
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predominantly entropy driven, consistent with the findings that skelemin is unable to
activate the receptors. We have built a tertiary model of αIIbβ3 integrin cytoplasmic tails
complexed with the tandem domains. While some of the interactions between K716 side
chain of β3 tail and skelemin may occur in the presence of αIIb subunit still bound to β3,
disruption of membrane-proximal α/β clasp and release of αIIb F992 and β3 H722/D723/E726
side chains is necessary for αIIb to bind to skelemin and for β3 to stabilize its interface with
skelemin. Thus, our model favors skelemin role as a stabilizer of the activated integrins
and integrin clusters by connecting α and β subunits from adjacent receptors.
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